Fact-checked by Grok 2 weeks ago

Radiochemistry

Radiochemistry is the branch of chemistry that studies the chemical properties, reactions, and behavior of radioactive elements and isotopes, employing techniques to isolate, synthesize, and analyze them under conditions of radioactivity.^[1] This field applies principles of radioactive decay and nuclear phenomena to investigate chemical processes, distinguishing it from broader nuclear chemistry by its focus on chemical manipulations of radionuclides.^[2] Radiochemists work with unstable isotopes that emit alpha, beta, or gamma radiation, necessitating specialized handling to mitigate hazards from ionizing radiation.^[3] The discipline originated in the late 19th century following Henri Becquerel's 1896 discovery of natural radioactivity in uranium salts, which prompted Pierre and Marie Curie to isolate radioactive elements like polonium and radium through laborious chemical separations.^[4] Key developments accelerated during World War II with the Manhattan Project, where radiochemical methods enabled the purification of uranium-235 and plutonium-239 for atomic bombs and reactors, establishing large-scale isotope production.^[4] Postwar advancements included the synthesis of transuranic elements beyond uranium, expanding the periodic table and probing nuclear stability limits.^[5] Radiochemistry underpins critical applications, including the nuclear fuel cycle for energy production, where processes like solvent extraction separate fissile materials from fission products.^[6] In medicine, it facilitates the production of radiopharmaceuticals for diagnostic imaging via positron emission tomography (PET) and targeted radiotherapy for cancer treatment using isotopes such as technetium-99m and iodine-131.^[7] Tracers derived from radiochemical labeling enable precise tracking of metabolic pathways in biology and environmental monitoring of pollutants, while radiometric dating techniques, like carbon-14 analysis, provide empirical timelines for archaeological and geological events.^[8] Despite these achievements, the field grapples with challenges in managing radioactive waste and ensuring radiation safety, as uncontrolled releases pose long-term environmental and health risks substantiated by dosimetry studies.^[9]

History

Discovery of Radioactivity and Early Pioneers

In 1896, French physicist Henri Becquerel discovered radioactivity while investigating phosphorescence in uranium salts in relation to the recently identified X-rays.^[10] On February 26, he placed uranium potassium sulfate on a photographic plate wrapped in black paper and stored it in a dark drawer; upon development, the plate showed a silhouette of the uranium sample, indicating emission of penetrating rays independent of light exposure.^[11] Further experiments confirmed that non-phosphorescent uranium salts produced the same effect spontaneously, leading Becquerel to conclude that uranium emitted invisible radiation continuously, a property he termed "uranic rays."^[12] This observation marked the initial empirical identification of natural radioactive decay, though Becquerel did not pursue extensive chemical separation or mechanistic explanations.^[13] Becquerel's findings prompted Pierre and Marie Curie to systematically explore radioactivity in minerals beyond uranium, focusing on chemical isolation of active components. In 1898, processing pitchblende ore—which exhibited higher activity than its uranium content—they isolated polonium, named after Marie's native Poland, with 400 times uranium's activity, and radium, over a million times more active.^[14] The Curies refined tons of pitchblende residue through fractional crystallization, enduring laborious manual separations in a poorly equipped shed; by 1902, Marie isolated 0.1 grams of pure radium chloride, determining its atomic weight as 225.93.^[15]^[16] Their work established radioactivity as an atomic property tied to specific elements, founding radiochemistry as a discipline blending nuclear emissions with chemical purification techniques, though early exposures caused health effects like Pierre's skin lesions from radium.^[17] For these contributions, Becquerel shared the 1903 Nobel Prize in Physics with the Curies; Marie received the 1911 Chemistry Nobel for radium and polonium isolation.^[18] Concurrent with the Curies, New Zealand-born physicist Ernest Rutherford advanced understanding by classifying radioactive emissions, informing radiochemical analyses. Arriving at McGill University in 1898, Rutherford in 1899 demonstrated two distinct radiation types from uranium: alpha rays, absorbed by thin metal foils and resembling charged particles, and beta rays, more penetrating like electrons.^[19]^[20] Collaborating with Frederick Soddy, he elucidated transformation chains, discovering radon gas as an intermediate and formulating the exponential decay law, with half-lives quantifying stability.^[21] These distinctions enabled targeted chemical separations, as alpha emitters like polonium differed from beta/gamma sources, earning Rutherford the 1908 Chemistry Nobel for proving atomic disintegration into new elements.^[22] Early radiochemists thus shifted from phenomenological detection to causal models of nuclear instability driving elemental transmutation.

World War II and Post-War Expansion

During World War II, radiochemistry played a pivotal role in the Manhattan Project, particularly in the development and isolation of fissile materials for atomic weapons. Chemists at the University of Chicago's Metallurgical Laboratory, led by Glenn T. Seaborg, focused on plutonium chemistry after its initial synthesis in 1940, devising chemical separation processes to extract it from irradiated uranium targets contaminated with fission products and other actinides.^[23] Seaborg's team evaluated multiple extraction methods, including lanthanum fluoride precipitation and solvent extraction, but prioritized the bismuth phosphate process for its scalability and selectivity in isolating plutonium(IV) ions under controlled redox conditions.^[24] This method was implemented at the Hanford Site in Washington state, where, by 1944, pilot-scale operations produced sufficient plutonium for the "Fat Man" bomb detonated over Nagasaki on August 9, 1945.^[25] Radiochemical techniques were essential for handling the intense radioactivity and short-lived isotopes generated in nuclear reactors and cyclotrons, enabling purification yields exceeding 90% in some separations despite challenges like corrosion from acidic media and radiation-induced decomposition of reagents.^[26] Concurrently, uranium enrichment efforts at Oak Ridge incorporated radiochemical monitoring to track isotopic compositions via beta counting and mass spectrometry, ensuring gaseous diffusion plants achieved the necessary 235U concentrations of over 80% for weapon-grade material.^[27] These wartime advances accelerated the field by integrating inorganic synthesis, ion-exchange chromatography, and hot-cell manipulations, though they were conducted under secrecy until the project's declassification in 1946. Post-war, radiochemistry expanded rapidly under the U.S. Atomic Energy Commission (AEC), established by the Atomic Energy Act of 1946, which centralized control over fissile materials and isotope production.^[28] Reactor operations at sites like Argonne National Laboratory and Brookhaven scaled up radioisotope yields, with the first shipments of carrier-free phosphorus-32 and iodine-131 for medical research occurring in 1946, fostering tracer applications in biology and agriculture.^[29] Seaborg's group at Berkeley continued transuranium element synthesis, isolating americium and curium by 1945–1946 using ion-exchange methods refined during the war, which revealed actinide contraction and advanced understanding of f-block chemistry.^[30] The 1950s saw radiochemistry diversify into nuclear fuel reprocessing and waste management, with the Purex process—adopted in 1954 at Savannah River—enabling efficient recovery of uranium and plutonium from spent fuel via tributyl phosphate extraction, processing thousands of tons annually by decade's end. Internationally, programs in the UK and France mirrored U.S. efforts, while the 1953 "Atoms for Peace" initiative distributed over 100,000 curies of isotopes globally by 1960, spurring radiopharmaceutical development and reactor design.^[31] This era's growth, fueled by Cold War demands and civilian energy pursuits, elevated radiochemistry from wartime exigency to a foundational discipline, though it highlighted persistent challenges in radiation safety and long-term actinide disposal.^[32]

Late 20th Century to Present Developments

The Chernobyl nuclear accident on April 26, 1986, released approximately 5,200 PBq of radionuclides into the environment, including significant quantities of cesium-137, strontium-90, and plutonium isotopes, necessitating advanced radiochemical techniques to study their speciation, soil adsorption, and long-term migration in ecosystems.^[33] These investigations revealed tight geochemical coupling between atmospheric deposition, terrestrial uptake, and aquatic transport, with radiocesium exhibiting high mobility in organic-rich soils due to complexation with humic substances.^[34] Post-accident radiochemistry emphasized hot-particle analysis and isotopic fingerprinting to distinguish Chernobyl-derived contamination from global fallout, informing remediation strategies like soil plowing and forest management.^[35] The 2011 Fukushima Daiichi accident, while releasing about ten times less radioactivity than Chernobyl—primarily volatile fission products like iodine-131 and cesium-137—further advanced environmental radiochemistry through improved in situ measurement of colloid-bound radionuclides and leaching models from fuel particles.^[33] ^[36] Studies highlighted slower cesium desorption from Fukushima-derived microparticles compared to Chernobyl's, attributing differences to matrix compositions and influencing predictive modeling for groundwater contamination.^[36] These events spurred development of ultra-sensitive techniques, such as accelerator mass spectrometry for attogram-level detection of actinides, enhancing global nuclear forensics and waste site monitoring.^[37] In medical radiochemistry, the late 1980s and 1990s saw widespread adoption of technetium-99m-based agents, with innovations like 99mTc-sestamibi for myocardial perfusion imaging approved by the FDA in 1990, enabling non-invasive cardiac diagnostics.^[38] The introduction of automated synthesis modules in the 1990s facilitated routine production of short-lived positron emitters like fluorine-18 for FDG-PET, revolutionizing oncology staging with quantitative metabolic imaging.^[39] By the 2000s, monoclonal antibody radiolabeling advanced, exemplified by the 2002 FDA approval of indium-111-ibritumomab tiuxetan for non-Hodgkin lymphoma therapy, marking a shift toward targeted radionuclide treatments.^[40] Theranostic applications expanded in the 2010s, with lutetium-177-PSMA for prostate cancer entering clinical trials around 2013 and gaining EMA approval in 2022, combining diagnostics and beta-emitter therapy in a single agent.^[41] Alpha-emitting radionuclides like actinium-225 gained traction for their high linear energy transfer, with initial human trials for targeted alpha therapy in leukemia reported in 2001 and broader oncology applications by the 2020s.^[42] Copper-mediated labeling techniques emerged prominently post-2010, offering stable chelation for 64Cu in PET imaging and 67Cu therapy, addressing supply chain vulnerabilities in reactor-produced isotopes.^[43] Fundamental radiochemistry experienced a renaissance from the 2000s, driven by synthesis of superheavy elements via heavy-ion fusion at facilities like GSI Helmholtz Centre and JINR Dubna, enabling first chemical characterizations of rutherfordium (element 104) in aqueous solutions by 1990s gas-phase chromatography experiments.^[44] Confirmation of elements 113–118 (nihonium to oganesson) between 2004 and 2016 relied on radiochemical separation of decay chains, probing relativistic effects on volatility and oxidation states.^[45] Ongoing efforts target element 119 and beyond, using radioactive beams to overcome fusion barriers, with predicted half-lives informing island-of-stability hypotheses.^[46] Contemporary trends include integration of radiochemistry with nanotechnology for enhanced targeting and AI-optimized isotope production, amid workforce shortages noted in U.S. surveys from 2022, underscoring needs for training in hot-cell manipulations and no-carrier-added syntheses.^[47] ^[37] These developments reflect radiochemistry's pivot toward precision applications, balancing medical efficacy with environmental stewardship.^[48]

Fundamental Principles

Radioactive Decay Processes

Radioactive decay processes are spontaneous nuclear transformations in which an unstable atomic nucleus emits particles or electromagnetic radiation to achieve a lower energy state, altering its composition or releasing excess energy. These processes follow probabilistic laws governed by quantum mechanics, with decay rates characterized by half-lives that remain constant regardless of external conditions like temperature or pressure.^[49] The primary decay modes include alpha, beta, and gamma emissions, alongside less common variants such as electron capture and spontaneous fission, each driven by the imbalance in nuclear forces or excess energy.^[50] Alpha decay occurs predominantly in heavy nuclei (atomic number Z > 82), where the nucleus emits an alpha particle—a helium-4 nucleus comprising two protons and two neutrons—reducing the mass number A by 4 and Z by 2, resulting in a daughter nucleus of a different element. This process is facilitated by quantum tunneling through the Coulomb barrier, despite the alpha particle's binding energy within the parent nucleus. For instance, uranium-238 undergoes alpha decay to thorium-234 with a half-life of approximately 4.468 billion years.^[51] Alpha particles have low penetrating power due to their +2 charge and mass of about 4 u, typically stopped by a sheet of paper.^[50] Beta decay encompasses two main subtypes: beta-minus (β⁻) and beta-plus (β⁺) decay, both conserving mass number A while changing Z by 1, often to correct neutron-proton imbalances in the nucleus. In β⁻ decay, a neutron transforms into a proton, emitting an electron and an antineutrino; this is common in neutron-rich nuclei, such as carbon-14 decaying to nitrogen-14 with a half-life of 5,730 years.^[52] Conversely, β⁺ decay involves a proton converting to a neutron, emitting a positron and a neutrino, prevalent in proton-rich lighter nuclei; it requires sufficient energy (at least 1.022 MeV for positron-electron pair production). Beta particles, whether electrons or positrons, exhibit greater penetration than alphas due to their lower mass and unit charge.^[50]^[53] Electron capture (EC) is an alternative to β⁺ decay in proton-rich nuclei, where the nucleus captures an inner-shell orbital electron, converting a proton to a neutron and emitting a neutrino; this increases Z by 1 while maintaining A, often followed by X-ray emission from atomic rearrangement. EC predominates when the energy available is low (less than 1.022 MeV), as it avoids positron emission's energy threshold, and is observed in isotopes like beryllium-7, which decays to lithium-7 with a half-life of 53.22 days.^[53] Unlike β⁺, EC does not produce charged particles directly, reducing external radiation but generating characteristic X-rays.^[50] Gamma decay, or isomeric transition, involves the de-excitation of an excited nuclear state (isomer) to its ground state by emitting a high-energy photon (gamma ray), without altering A or Z; it frequently accompanies alpha or beta decay when the daughter nucleus retains excess energy. Gamma rays, being electromagnetic radiation with energies from keV to MeV, possess high penetrating power and require dense shielding like lead. For example, technetium-99m, widely used in medical imaging, undergoes gamma decay with a half-life of 6.01 hours, emitting 140 keV photons.^[54] Internal conversion, a competing process, occurs when the gamma energy is transferred to an orbital electron instead, ejecting it as an Auger or conversion electron.^[53] Spontaneous fission (SF) is a rare decay mode in very heavy nuclei (Z ≥ 90), where the nucleus splits into two lighter fragments plus neutrons without external stimulation, driven by shell instabilities and quantum tunneling through fission barriers. Unlike induced fission, SF rates are low; californium-252, for instance, has an SF half-life of about 2.645 years, emitting on average 3-4 neutrons per event. This process contributes to the background neutron flux in reactors and limits the stability of superheavy elements.^[53] Other exotic modes, such as proton or cluster emission, occur in highly proton-rich or deformed nuclei but are negligible for most radiochemical contexts.^[50]

Nuclear Reactions and Isotope Production

Nuclear reactions in radiochemistry primarily involve inducing transformations in atomic nuclei to produce radionuclides, either through neutron interactions in reactors or charged-particle bombardments in accelerators. These reactions enable the synthesis of isotopes with specific decay properties for applications in medicine, research, and industry. Key processes include neutron capture, fission, and charged-particle reactions, selected based on the target's nuclear stability and desired isotopic yield.^[55] In nuclear reactors, isotope production relies on high neutron fluxes to drive reactions such as thermal neutron capture, denoted as (n,γ), where a target nucleus absorbs a neutron and emits a gamma ray, forming a neutron-rich isotope. For example, irradiation of tellurium-123 yields iodine-124 via ^{123}Te(n,γ)^{124}Te → ^{124}I + β^-, though yields depend on neutron energy and flux, typically 10^{13} to 10^{15} n/cm²/s in research reactors. Fission reactions in uranium-235 targets, induced by thermal neutrons, produce fission fragments like molybdenum-99 (yield ~6% per fission), which decays to technetium-99m, the most widely used medical radioisotope in over 80% of procedures. Reactor-based methods favor neutron-excess isotopes due to the abundance of low-energy neutrons, with production scales reaching curie to megacurie levels for high-demand nuclides.^[55]^[7]^[56] Accelerator-based production, often using cyclotrons, employs charged particles like protons or deuterons to bombard targets, inducing reactions such as (p,n) or (d,n) that convert stable nuclei into proton-deficient isotopes suitable for positron emission tomography (PET). A prominent example is the production of fluorine-18 via the ^{18}O(p,n)^{18}F reaction on enriched oxygen-18 water targets, with optimal energies around 11-18 MeV yielding specific activities exceeding 10^{10} Bq/μmol. Deuteron reactions, like ^{nat}Mo(d,p)^{99}Mo, offer alternatives to reactor fission for molybdenum-99, though with lower yields requiring higher beam currents (up to 2 mA). Cyclotrons accelerate particles in spiral paths via alternating electric fields and static magnetic fields, enabling on-site production of short-lived isotopes (half-lives <2 hours) that cannot tolerate transport delays from centralized reactors.^[57]^[58]^[59] Photonuclear reactions, induced by high-energy gamma rays from electron accelerators, provide niche production routes, such as (γ,n) on heavy targets for neutron-deficient isotopes, but remain limited by lower cross-sections (typically <100 mb) compared to charged-particle methods (up to 1 b). Hybrid approaches, including neutron generation via fusion (e.g., D-D or D-T reactions producing 2.45 or 14.1 MeV neutrons), are emerging for reactor-independent yields, though scalability challenges persist. Selection of reaction routes involves evaluating excitation functions, isotopic purity, and coproduced contaminants, with cross-section data from databases guiding optimal beam parameters.^[60]^[61]

Radiochemical Equilibria and Kinetics

Radiochemical equilibria in decay chains arise when production and decay rates of daughter nuclides balance, enabling predictable isotope ratios for applications such as radionuclide generators. Secular equilibrium establishes when the parent's half-life greatly exceeds the daughter's, such that the daughter's decay rate equals the parent's, yielding equal activities after sufficient time; for instance, in the ^{226}Ra (half-life 1,600 years) to ^{222}Rn (half-life 3.8 days) pair, the Rn activity approximates Ra's over short observation periods relative to Ra's longevity.^[62]^[63] Transient equilibrium occurs when the parent's half-life exceeds the daughter's but not by orders of magnitude, resulting in the daughter's activity surpassing the parent's by the factor \lambda_p / (\lambda_p - \lambda_d), where \lambda denotes decay constants; this condition underpins generators like ^{99}Mo (half-life 66 hours) decaying to ^{99m}Tc (half-life 6 hours), with Tc activity reaching about 1.1 times Mo's at equilibrium.^[64]^[65] Kinetics of these equilibria follow the Bateman equations, which model multi-step decay chains via differential equations for nuclide concentrations N_i(t) = (production rate) \times \sum [terms involving decay constants and time exponentials], solving for transient buildup toward equilibrium. In chemical contexts, radiochemical equilibria include isotope exchange reactions, where radioisotopes distribute between phases according to separation factors driven by mass-dependent vibrational frequency shifts; for lithium isotopes in amalgam-organic solution exchanges, elementary separation factors reflect these effects, enabling purification via repeated equilibrations.^[66]^[67] Radiochemical kinetics extend beyond decay to encompass reactions of "hot" atoms—recoil species from nuclear events possessing keV to MeV kinetic energies, far exceeding thermal values—which induce non-thermal reaction mechanisms like bond ruptures and radical formations before thermalization.^[68] In hot atom chemistry, these energetic atoms, produced via neutron capture or (n,\gamma) reactions, exhibit reaction cross-sections independent of activation energy barriers, yielding products such as labeled organics in radiopharmaceutical synthesis; for example, ^{18}F atoms from cyclotron production react with precursors via direct substitution, bypassing conventional pathways.^[69] Such kinetics inform isotope labeling efficiencies, with recoil energies dissipating through collisions, often moderated by cage effects in condensed phases that limit diffusion and favor intramolecular reactions.^[70] Ion exchange kinetics for radioisotopes, traced via tracers like ^{137}Cs or ^{60}Co, reveal equilibrium constants from forward and reverse rates, supporting chromatographic separations where distribution coefficients predict retention times.^[71] These processes highlight radiation's causal role in altering reaction landscapes, distinct from thermal chemistry due to localized energy deposition.

Techniques and Methods

Radionuclide Production Methods

Radionuclides for radiochemical applications are produced through three primary methods: nuclear reactors, particle accelerators such as cyclotrons, and radionuclide generators.^[72] Reactor-based production leverages neutron irradiation to generate neutron-rich isotopes suitable for beta-minus emitters, while accelerators produce neutron-deficient isotopes via charged-particle reactions, often yielding positron emitters for imaging. Generators exploit the decay of a longer-lived parent radionuclide to supply short-lived daughters on demand, enabling decentralized use in clinical settings.^[73] These methods are selected based on the desired isotope's nuclear properties, half-life, and required purity, with reactor production dominating for bulk quantities of therapeutic radionuclides and cyclotrons enabling on-site synthesis of short-lived diagnostics.^[74] In nuclear reactors, radionuclides arise from either fission of heavy nuclei like uranium-235 or neutron activation of target materials. Fission occurs when thermal neutrons split U-235 atoms, releasing fission products such as molybdenum-99 (half-life 66 hours), which constitutes about 6% of typical yields and serves as a precursor for technetium-99m.^[75] This process produces neutron-rich isotopes with high specific activity but requires chemical separation from uranium fuel and other fragments, often via solvent extraction or chromatography. Neutron activation involves exposing stable isotopes to high thermal neutron fluxes (typically 10^14 neutrons/cm²/s) in reactor channels, inducing (n,γ) reactions to form isotopes like cobalt-60 (from Co-59 capture, half-life 5.27 years) or iodine-131 (from Te-130 via successive captures).^[74] Production routes prioritize reactors for isotopes needing high neutron fluxes, with targets irradiated for durations matched to saturation factors determined by half-life and flux intensity.^[76] Particle accelerators, particularly cyclotrons, accelerate protons or deuterons (energies 10-30 MeV) onto enriched targets to induce (p,n), (p,α), or similar reactions, generating proton-rich radionuclides. For instance, fluorine-18 is produced via the ¹⁸O(p,n)¹⁸F reaction on enriched water targets, yielding positron-emitting isotopes with half-lives under 2 hours, ideal for PET imaging.^[58] Cyclotrons operate in high vacuum with alternating electric fields and static magnetic fields to spiral particles into targets, producing no-carrier-added (high specific activity) isotopes but limited batch sizes due to beam currents (typically 100-500 μA).^[59] This method suits neutron-deficient nuclides unavailable via reactors, with over 200 medical cyclotrons worldwide as of 2023 facilitating daily production of carbon-11, nitrogen-13, and gallium-68.^[77] Radionuclide generators provide short-lived daughters from the ingrowth of a longer-lived parent fixed on a column, allowing repeated elution without on-site irradiation. The paradigmatic ⁹⁹Mo/⁹⁹ᵐTc generator uses fission-produced ⁹⁹Mo (half-life 66 hours) adsorbed on alumina, from which pertechnetate (⁹⁹ᵐTcO₄⁻, half-life 6 hours) is selectively eluted with saline, achieving secular equilibrium where daughter activity approaches parent levels.^[78] Similarly, ⁶⁸Ge/⁶⁸Ga generators (⁶⁸Ge half-life 271 days) employ TiO₂ or SnO₂ matrices for ⁶⁸Ga elution via EDTA or HCl, supporting PET theranostics with yields up to 80% per elution cycle.^[79] Generator efficacy depends on parent-daughter separation chemistry to minimize breakthrough contamination (e.g., <0.01% ⁹⁹Mo in eluate), with systems refreshed weekly or monthly based on parent decay.^[80] These devices extend isotope accessibility beyond centralized facilities, though parent supply chains remain reactor- or accelerator-dependent.^[81]

Separation and Purification Techniques

Separation and purification techniques in radiochemistry exploit differences in chemical and physical properties of radionuclides and their compounds to isolate specific isotopes from complex matrices such as irradiated targets, fission product mixtures, or environmental samples. These methods are critical for achieving high purity, often exceeding 99.9%, to minimize unwanted radioactivity and chemical impurities that could interfere with applications like medical imaging or therapy. Due to the hazards of handling radioactive materials, procedures frequently involve remote manipulation in gloveboxes or hot cells, with rapid processing to accommodate short-lived isotopes.^[82] Precipitation and coprecipitation are foundational techniques where target radionuclides are converted to insoluble forms or adsorbed onto carrier precipitates. In coprecipitation, trace radionuclides co-precipitate with a macroscopically observable carrier salt, such as ferric hydroxide for actinides, leveraging surface adsorption or inclusion mechanisms; decontamination factors can reach 10^4 to 10^6 per step. For example, radium is precipitated as radium sulfate from barium sulfate carriers, achieving separation from other alkaline earths based on solubility differences. These methods are simple and cost-effective but may require multiple steps for high purity and can suffer from incomplete recovery if isotopic exchange occurs.^[83]^[84] Solvent extraction, or liquid-liquid extraction, separates radionuclides based on differential partitioning between aqueous and organic phases, often using chelating agents like tributyl phosphate (TBP) for actinides. Distribution coefficients (D) guide selectivity; for instance, uranyl nitrate extracts into TBP-diluent systems with D > 100 under nitric acid conditions, enabling separation from fission products. Developed extensively for nuclear fuel reprocessing, this technique scales well for large volumes and provides high throughput, with processes like PUREX achieving over 99.9% uranium and plutonium recovery. Challenges include emulsion formation and radiolytic degradation of extractants, necessitating fresh solvent feeds.^[85]^[86] Ion exchange chromatography utilizes resins with fixed charges to selectively bind ionic radionuclides, eluting them via concentration or pH gradients. Cation exchangers like Dowex-50 separate actinides from lanthanides based on charge density, while anion exchangers target pertechnetate or iodate forms. In the Manhattan Project, ion exchange purified fission rare earths, demonstrating scalability; modern variants include extraction chromatography with supported liquid membranes for radionuclides like 99Tc or 129I. Decontamination efficiencies exceed 10^5, but column capacity limits apply to high-activity samples, and radiation damage to resins requires periodic replacement.^[87]^[88] Other specialized methods include distillation for volatile species like iodine or ruthenium, exploiting boiling point differences under reduced pressure to avoid decomposition, and electrochemical separations where electrodeposition plates metals like plutonium onto cathodes with >95% efficiency. These complement primary techniques in multi-step protocols, with overall purification validated by gamma spectroscopy or alpha counting to confirm isotopic purity.^[89]^[90]

Detection, Measurement, and Analysis

Detection of radioactive isotopes in radiochemical samples primarily exploits the ionizing effects of alpha, beta, and gamma radiation on matter, generating measurable electrical pulses, light flashes, or charge carriers. Gas-filled detectors, such as Geiger-Müller counters and ionization chambers, operate by collecting ion pairs formed when radiation ionizes the fill gas, enabling beta and gamma detection with efficiencies varying by window material and voltage bias.^[91] ^[92] Scintillation detectors, using materials like sodium iodide doped with thallium (NaI(Tl)), convert radiation energy into photons that are then amplified by photomultiplier tubes, offering higher sensitivity for gamma spectrometry and pulse-height analysis to identify nuclides by energy peaks.^[93] ^[91] Semiconductor detectors, particularly high-purity germanium (HPGe), provide superior energy resolution for gamma-ray spectroscopy due to their low noise and precise charge collection in a depleted semiconductor junction, though they require cryogenic cooling to minimize thermal noise.^[93]^[91] Measurement of radioactivity quantifies decay events per unit time, typically in becquerels (Bq; one decay per second) or curies (Ci; 3.7 × 10^10 decays per second), using counting techniques that account for decay law statistics where the standard deviation equals the square root of counts for Poisson-distributed events.^[94] Alpha and beta emitters are often measured via proportional counters or liquid scintillation, with efficiencies corrected for self-absorption and geometry using calibrated standards, while gamma emitters employ full-energy peak efficiencies derived from known sources like ^{137}Cs (662 keV).^[95] ^[93] Half-life determination involves serial activity measurements fitted to exponential decay curves, with uncertainties propagated from counting errors and background subtraction, essential for verifying nuclide identity in reactor-produced isotopes.^[95] Radiochemical analysis integrates separation techniques with detection to resolve isobaric interferences and achieve low-level quantification, as direct counting often yields unresolved spectra in complex matrices. Common separations include solvent extraction (e.g., tributyl phosphate for actinides), ion-exchange chromatography, and precipitation, followed by alpha spectrometry using silicon surface-barrier detectors for isotopic ratios like ^{238}U/^{234}U.^[96] ^[97] Gamma-ray spectrometry with HPGe detectors identifies multiple nuclides non-destructively via multi-peak deconvolution, calibrated against NIST-traceable standards, though matrix effects necessitate empirical efficiency curves.^[98] ^[99] For trace analysis, neutron activation analysis (NAA) irradiates samples to produce measurable daughter isotopes, detected post-cooling by gamma spectroscopy, offering parts-per-billion sensitivity for elements like ^{59}Co from stable cobalt.^[93] Quality assurance in these methods emphasizes traceability to primary standards, blank corrections, and yield tracers (e.g., ^{243}Am for americium separations) to ensure accuracy within 5-10% for environmental monitoring.^[99] ^[97]

Applications

Medical and Theranostic Uses

Radiochemistry underpins nuclear medicine by enabling the synthesis, purification, and application of radiopharmaceuticals, which are compounds incorporating radionuclides for targeted delivery to physiological or pathological sites in the body. These agents exploit radioactive decay processes, such as beta emission for therapy or gamma emission for imaging, to achieve diagnostic or therapeutic effects with high specificity. Production typically involves nuclear reactions in reactors or cyclotrons to generate isotopes like molybdenum-99 (for technetium-99m) or fluorine-18, followed by radiochemical separations to yield pure agents suitable for human use.^[100]^[101] In diagnostic applications, technetium-99m (Tc-99m), with a 6-hour half-life and gamma emission at 140 keV, dominates single-photon emission computed tomography (SPECT) scans, accounting for approximately 80% of nuclear medicine procedures worldwide as of 2023. Tc-99m is chelated to ligands like sestamibi for myocardial perfusion imaging or MDP for bone scans, allowing detection of ischemia or metastases with sensitivity exceeding 90% in validated studies. Positron emission tomography (PET) relies on positron emitters such as fluorine-18 (half-life 110 minutes), incorporated into 2-deoxy-2-[18F]fluoro-D-glucose (FDG) to quantify glucose metabolism in tumors, where standardized uptake values correlate with malignancy grades in cancers like non-small cell lung carcinoma.^[7]^[102] Therapeutic uses harness beta- or alpha-emitting radionuclides to deliver ionizing radiation selectively to diseased tissues, minimizing off-target damage compared to external beam radiotherapy. Iodine-131 (I-131), a beta emitter with a 8-day half-life, has treated hyperthyroidism and thyroid cancer since the 1940s, achieving remission rates of 80-90% in differentiated thyroid carcinoma post-thyroidectomy when dosed at 100-200 mCi. For prostate cancer bone metastases, radium-223 (alpha emitter, 11.4-day half-life) extends median overall survival by 3.6 months versus placebo, as demonstrated in the phase III ALSYMPCA trial involving 921 patients. Lutetium-177 (Lu-177, beta emitter, 6.7-day half-life) conjugated to prostate-specific membrane antigen (PSMA) inhibitors treats metastatic castration-resistant prostate cancer, with phase II trials reporting prostate-specific antigen declines in over 50% of patients and objective response rates of 30-40%.^[103]^[104] Theranostics integrates diagnostics and therapy using matched radionuclide pairs with identical targeting vectors, allowing dosimetry-informed treatment personalization. A prime example is gallium-68 (Ga-68, positron emitter for PET) paired with Lu-177 for PSMA-targeted agents in prostate cancer; Ga-68-PSMA-11 PET/CT identifies lesions with 90% sensitivity, guiding Lu-177-PSMA therapy that yields partial responses in 40-60% of advanced cases per VISION trial data from 831 patients, improving survival by 4 months. Similarly, indium-111 or yttrium-90 analogs predict dosimetry for peptide receptor radionuclide therapy in neuroendocrine tumors, where somatostatin analogs labeled with these isotopes achieve tumor control rates of 70-80% empirically. This approach, rooted in radiochemical equilibria for stable chelation (e.g., DOTA macrocycles), enhances causal efficacy by verifying target expression prior to high-dose administration.^[105]^[106]

Environmental and Geochemical Analysis

Radiochemical methods enable the precise detection and quantification of radionuclides in environmental matrices such as water, soil, sediment, and biota, facilitating the assessment of contamination from anthropogenic sources like nuclear accidents or weapons testing. Techniques often involve sample preconcentration, chemical separation to isolate specific isotopes, and detection via gamma-ray spectrometry for emitters like cesium-137 (¹³⁷Cs) or alpha/beta counting after purification, achieving detection limits as low as 0.1 Bq/kg in solids.^[99] ^[107] These approaches are standardized by agencies like the U.S. Environmental Protection Agency for routine monitoring, ensuring consistency across laboratories in analyzing effluents, airborne particles, and building materials post-incident.^[108] Automated flow systems have enhanced efficiency for high-volume environmental radioactivity surveillance, particularly in nuclear emergency response.^[109] In geochemical studies, natural and fallout radionuclides serve as tracers for dynamic earth processes, including sediment transport, erosion, and biogeochemical cycling. For example, short-lived isotopes in the uranium-thorium series, such as thorium-234 (²³⁴Th, half-life 24.1 days), quantify particle scavenging and export fluxes in oceans by measuring disequilibria with parent uranium-238 (²³⁸U), revealing carbon sinking rates on timescales of weeks.^[110] Similarly, polonium-210 (²¹⁰Po) and lead-210 (²¹⁰Pb) track particulate organic matter remineralization in coastal waters, with ²¹⁰Pb profiles dating sediments and estimating accumulation rates at 0.1–1 cm/year in many marine settings.^[111] Anthropogenic tracers like ¹³⁷Cs (half-life 30.17 years), deposited globally from 1960s atmospheric tests peaking in 1963, delineate soil erosion patterns; downslope redistribution exceeding 10–20% of inventory indicates annual erosion losses of 5–20 t/ha in agricultural fields.^[112] Hydrogeological applications leverage both natural and introduced radionuclides for groundwater dating and flow path reconstruction. Tritium (³H, half-life 12.32 years) from 1950s–1960s bomb tests dates modern recharge waters up to 60 years old, while longer-lived species like carbon-14 (¹⁴C, half-life 5730 years) and chlorine-36 (³⁶Cl, half-life 301,000 years) extend chronologies to millennia, correcting for dilution and geochemical retardation via models like the dispersion model.^[113] In post-accident scenarios, such as Chernobyl in 1986, radionuclides like ¹³⁷Cs and strontium-90 (⁹⁰Sr) traced the tight coupling of atmospheric deposition, terrestrial runoff, and aquatic bioaccumulation, with lake sediments showing initial peaks followed by exponential decay modulated by sedimentation rates of 0.2–0.5 cm/year.^[34] These tracers reveal causal pathways, such as enhanced mobility of ¹³⁷Cs in organic-rich soils (Kd > 10⁴ mL/g) versus sands, informing remediation strategies without relying on biased modeling assumptions.^[114]

Industrial and Materials Applications

Radioisotopes function as tracers in industrial processes to track fluid flow, filtration efficiency, leak detection, and material degradation such as engine wear and corrosion. In the oil and gas sector, they delineate reservoir boundaries and optimize production by mapping fluid movement within wells and pipelines. For example, tritiated water (hydrogen-3, half-life 12.3 years) traces sewage dispersion and liquid waste pathways, enabling precise environmental and process monitoring. These applications leverage the detectability of radioactive emissions to provide data unattainable through conventional methods, often reducing operational costs by identifying inefficiencies without system disassembly.^[115] Nucleonic gauges utilize radioisotopes for non-invasive measurements of material properties, including thickness, density, and fill levels in containers or pipelines. Beta particle gauges assess thin materials like plastic films or paper moving at speeds up to 400 meters per minute, while gamma gauges monitor slurry densities in processes such as detergent manufacturing or coal handling. Fixed gauges on offshore platforms ensure safe liquid levels, and portable variants compact soil for construction stability; the International Atomic Energy Agency estimates hundreds of thousands of such devices deployed worldwide, enhancing precision in manufacturing and resource extraction.^[115]^[116] In materials inspection and analysis, gamma radiography employs sealed sources like iridium-192 (half-life 73.8 days) to detect flaws in welds, pipelines, and structural components without surface disruption, as demonstrated in post-disaster assessments following the 2015 Nepal earthquake. Backscatter techniques measure coating thicknesses on metals, while neutron radiography reveals internal compositions in materials such as cement or alloys. Additionally, cobalt-60 irradiation sterilizes industrial equipment and enhances fuel oil burner reliability by eliminating microbial contaminants, extending service life in harsh environments. These radiochemical methods support quality control and failure prediction, grounded in the predictable attenuation of radiation through matter.^[115]^[117]

Safety, Health Effects, and Risk Assessment

Radiation Protection Standards and Practices

Radiation protection in radiochemistry follows the three fundamental principles established by the International Commission on Radiological Protection (ICRP): justification, optimization, and dose limitation. Justification requires that any exposure be justified by the benefits outweighing the risks, optimization mandates keeping exposures as low as reasonably achievable (ALARA) through engineering and procedural controls, and dose limitation sets maximum permissible doses to prevent deterministic effects and limit stochastic risks.^[118]^[119] Dose limits for occupational exposure, as recommended by ICRP Publication 103, include an effective dose of 20 mSv per year averaged over 5 consecutive years, with no single year exceeding 50 mSv; for the lens of the eye, 20 mSv per year averaged over 5 years; and for skin and extremities, 500 mSv per year. Public exposure is limited to 1 mSv per year effective dose. These standards are adopted in IAEA's General Safety Requirements, GSR Part 3, which harmonize international basic safety standards for protection against ionizing radiation. In the United States, the Nuclear Regulatory Commission (NRC) enforces similar limits under 10 CFR Part 20: 50 mSv (5 rem) per year whole-body effective dose for workers, with public limits at 1 mSv (0.1 rem) per year and 5 mSv (0.5 rem) for infrequent exposures.^[120]^[121]^[122] ALARA is implemented by minimizing exposure time, maximizing distance from sources (intensity decreases with square of distance), and using shielding materials like lead for gamma rays, plastic for betas, and concrete or water for neutrons. In radiochemistry laboratories, engineering controls include fume hoods with HEPA filtration, gloveboxes for manipulating unsealed radionuclides, and hot cells for high-activity sources to contain contamination and aerosols.^[119]^[123] Administrative practices encompass personnel training, dosimetry monitoring (e.g., thermoluminescent dosimeters or electronic personal dosimeters), routine surveys with Geiger-Müller counters or scintillation detectors for contamination, and strict protocols for waste segregation, storage, and decay-in-storage for short-lived isotopes. Personal protective equipment includes lab coats, gloves, and shoe covers, with mandatory hand monitoring before leaving controlled areas to prevent inadvertent spread. Emergency procedures involve decontamination protocols, spill response kits, and declaration of restricted areas with postings and access controls.^[124]^[125]^[126] Regulatory compliance requires radiation safety officers to oversee programs, conduct audits, and ensure records of exposures remain below limits, with provisions for declared pregnant workers limited to 1 mSv to the fetus over the gestation period. Empirical data from long-term monitoring in nuclear facilities indicate that adherence to these standards maintains average occupational doses well below limits, often under 1 mSv per year, underscoring the effectiveness of layered defenses.^[122]^[127]

Health Impacts from Empirical Data

Empirical data on health impacts from radiation exposure in radiochemistry derive primarily from occupational cohorts handling radionuclides, accident investigations, and large-scale epidemiological studies of similar exposures. Acute deterministic effects occur at high doses (>1 Gy equivalent), manifesting as radiation syndromes affecting hematopoietic, gastrointestinal, and neurovascular systems. In the 1999 Tokaimura criticality accident during uranium fuel processing—a radiochemical operation—two workers received estimated whole-body doses of 16-20 Gy (neutron and gamma), resulting in acute radiation syndrome, chromosomal aberrations exceeding 20% dicentrics, bone marrow aplasia, and fatalities from multi-organ failure after 83 and 211 days; a third worker with ~3 Gy survived following hematopoietic stem cell transplantation but experienced chronic immunosuppression and skin damage.^[128]^[129] Chronic stochastic effects, particularly cancer induction, are assessed via cohorts with protracted low-to-moderate exposures relevant to routine radiochemical handling of alpha, beta, and gamma emitters. The Mayak Production Association worker cohort, exposed to plutonium via inhalation and systemic uptake during early radiochemical plutonium separation (1948-1972), exhibited dose-dependent elevations in lung cancer (primarily from alpha-irradiated bronchial epithelium), liver, and bone sarcomas, with excess relative risks correlating to cumulative internal doses >200 mGy to target organs; external gamma exposures also contributed to overall solid cancer mortality.^[130]^[131] In contrast, modern low-dose cohorts like INWORKS (308,932 nuclear workers, mean cumulative external dose 21.4 mSv from 1943-2005) report a modest increase in solid cancer mortality (ERR 0.52 per Gy, 90% CI 0.27-0.77, lagged 10 years), equating to ~0.5% excess per 10 mSv, though absolute attributable risks remain below 1% of total cancers.^[132] Other occupational analyses indicate no excess or even reduced all-cancer standardized mortality ratios (e.g., RR 0.85, 95% CI 0.75-0.97) among nuclear facility workers versus general populations, attributable to selection for healthy individuals and lifestyle factors confounding background risks.^[133] Atomic bomb survivor data (Life Span Study, doses 0-4 Gy) confirm linear-quadratic dose responses for leukemia (peaking 5-10 years post-exposure) and solid cancers at >100 mSv, but statistical power diminishes below this threshold, with no definitive excess detectable at typical occupational levels <50 mSv/year.^[134] Internal exposures in radiochemistry, monitored via bioassay, show organ-specific risks (e.g., thyroid from volatile iodines), but UNSCEAR evaluations of low-dose scenarios find attributable effects indistinguishable from baseline variability.^[135] Overall, while high-dose empirical outcomes establish causal links to cytotoxicity and oncogenesis, low-dose data highlight uncertainties, with risks likely overstated by extrapolations beyond observed ranges.

Environmental Fate and Transport

Radionuclides enter the environment primarily through accidental releases, such as nuclear reactor incidents or weapons testing, and their subsequent fate is determined by decay processes, dilution, and interactions with environmental media.^[136] Physical properties like half-life dictate persistence—short-lived isotopes like iodine-131 (half-life 8 days) decay rapidly, while long-lived ones such as cesium-137 (half-life 30.2 years) and plutonium-239 (half-life 24,100 years) remain mobile for decades or longer.^[137] Chemical speciation influences solubility and sorption; for example, oxidized forms of plutonium are more mobile in oxygenated waters than reduced forms that precipitate as hydroxides.^[138] Atmospheric transport involves dispersion of radioactive aerosols and gases, governed by plume dynamics and meteorological conditions. In unstable atmospheres, plumes spread more widely due to enhanced turbulence, increasing downwind deposition over larger areas, whereas stable conditions promote lofting and reduced ground-level concentrations.^[139] Wet deposition via precipitation scavenges particles efficiently, as observed in post-Chernobyl fallout where rain accelerated cesium and strontium transfer to soils across Europe in April-May 1986.^[140] Dry deposition dominates in arid regions, with particle size affecting settling velocity—fine aerosols (<1 μm) remain suspended longer, facilitating long-range transport thousands of kilometers.^[141] In terrestrial systems, radionuclide migration through soils occurs via advection with infiltrating water, diffusion, and colloidal transport, but is often retarded by adsorption to clay minerals and organic matter. Cesium-137 binds strongly to frayed edge sites on illite clays, yielding distribution coefficients (Kd) exceeding 10^4 mL/g in temperate soils, limiting vertical migration to 1-5 cm per year in undisturbed profiles.^[142] Horizontal transport via surface runoff is enhanced on slopes, with solubility playing a key role; highly soluble species like strontium-90 migrate faster than insoluble ones like americium-241.^[143] In groundwater, fracture flow in fractured rock aquifers can accelerate movement, though matrix diffusion into low-permeability zones provides natural retardation, as evidenced by minimal off-site migration from Chernobyl's near-field contaminated zones.^[144] Aquatic environments facilitate broader dispersal through rivers, lakes, and oceans, where radionuclides partition between dissolved, particulate, and sedimentary phases. In freshwater systems, sorption to suspended sediments leads to sedimentation in reservoirs, reducing downstream transport; for instance, particle-reactive plutonium isotopes show high affinity for iron-manganese oxides, with Kd values around 10^5-10^6 mL/g.^[145] Estuarine mixing zones promote flocculation and deposition, trapping contaminants, while oceanic currents distribute soluble species globally, as seen with Fukushima-derived cesium-134/137 detected in North Pacific waters by 2015.^[146] Bioaccumulation amplifies concentrations in food webs, quantified by bioconcentration factors (BCF); freshwater fish exhibit BCFs for cesium-137 of 10^2-10^4 L/kg wet weight, varying with trophic status—eutrophic lakes show higher uptake due to increased biomass turnover.^[147]^[148] Plants and invertebrates in contaminated soils uptake radionuclides via roots, with transfer factors (soil-to-plant) for strontium-90 reaching 10^{-1} in grasses on sandy soils.^[138] Predictive modeling integrates these processes using tools like advection-dispersion equations coupled with geochemical speciation, as in EPA's radiological fate simulations, to assess long-term risks under varying climate scenarios where increased precipitation may enhance leaching and remobilization.^[136]^[137] Empirical data from sites like Chernobyl confirm that while initial dispersion is rapid, immobilization and decay dominate long-term fate, with groundwater risks often below intervention thresholds.^[144]

Controversies and Debates

Public Perception vs. Scientific Evidence

Public apprehension toward radiochemistry and radiation exposure often stems from high-profile nuclear incidents, such as the 1986 Chernobyl accident, which fostered "radiophobia"—a term describing exaggerated fear disproportionate to actual radiological risks. Post-Chernobyl studies documented widespread psychological effects, including elevated rates of anxiety, depression, and suicides among evacuees and liquidators, exceeding direct radiation-induced fatalities estimated at around 4,000 long-term cancer deaths by the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). This fear has persisted, influencing public opposition to nuclear technologies despite radiochemistry's role in non-power applications like medical diagnostics, where misperceptions amplify perceived dangers from trace-level exposures.^[149]^[150]^[151] Scientific evidence contrasts sharply with these perceptions, revealing that low-dose radiation from radiochemical procedures poses negligible risks relative to benefits. Annually, over 20 million nuclear medicine scans in the United States utilize short-lived radioisotopes for precise disease detection, with effective doses typically 5-15 millisieverts (mSv)—comparable to or below annual natural background radiation of about 3 mSv—yielding diagnostic accuracies unattainable by non-radioactive methods. Empirical data from large cohorts, including atomic bomb survivors and occupational exposures, indicate no statistically significant cancer excess at doses below 100 mSv, challenging the linear no-threshold (LNT) model's extrapolation of high-dose risks to low levels, though LNT remains the regulatory baseline for conservatism.^[152]^[153]^[154] Further, some peer-reviewed analyses support radiation hormesis, where low doses (e.g., 10-100 mSv) stimulate cellular repair mechanisms, potentially reducing overall disease incidence, as observed in extended lifespans of irradiated model organisms and lower cancer rates in high-background radiation areas like Ramsar, Iran. Radiochemical applications in therapy, such as iodine-131 for thyroid cancer, achieve cure rates over 90% with controlled dosing, underscoring causal benefits from targeted radionuclide decay rather than indiscriminate harm. While media and certain advocacy sources amplify rare mishaps, longitudinal health data affirm radiochemistry's safety profile, with procedural risks far lower than alternatives like invasive surgeries.^[155]^[156]^[7]

Regulatory Overreach and Field Decline

Stringent regulations governing the handling, use, and disposal of radioactive materials have been identified as a key factor contributing to the decline of radiochemistry as an academic and research discipline. In the United States, oversight by the Nuclear Regulatory Commission (NRC) and Food and Drug Administration (FDA) requires extensive licensing, radiation safety training, and compliance with standards such as the As Low As Reasonably Achievable (ALARA) principle, which impose significant administrative and financial burdens on institutions, particularly smaller university laboratories.^[157]^[158] These requirements, intensified following incidents like the 1979 Three Mile Island accident and the 1986 Chernobyl disaster, have led to the closure of many radiochemistry facilities due to escalating costs for waste management and infrastructure upgrades, deterring new program development.^[158] Critics, including nuclear industry analysts, contend that this regulatory framework represents overreach by prioritizing hypothetical worst-case risks over empirical evidence of low incident rates in controlled radiochemical operations, effectively stifling innovation and education in the field.^[159] For instance, the high expense of radioactive waste disposal—often thousands of dollars per small volume—combined with lengthy approval processes for isotope procurement, has made routine experiments prohibitive for underfunded academic settings, resulting in fewer trained personnel entering the workforce.^[158]^[2] This has exacerbated a generational gap, with retirements outpacing recruitment; the National Science Foundation ceased tracking radiochemistry PhD graduates in 2003 due to their dwindling numbers, reflecting a broader contraction from approximately 30 U.S. university programs in the 1980s to a handful today.^[2] The interplay of these regulations with alternative non-radioactive techniques, such as fluorescence labeling, has further accelerated the field's marginalization, as younger researchers opt for methods unencumbered by such oversight.^[158] While proponents of the current regime emphasize public safety, empirical data on radiation exposures in research settings show doses typically far below regulatory limits, suggesting that the precautionary approach may have unintended causal effects, including reduced expertise available for critical applications like nuclear medicine and environmental monitoring.^[2] Efforts to reform, such as streamlining NRC pathways for advanced reactors, highlight ongoing debates over balancing protection with scientific progress, though similar alleviations for basic radiochemistry research remain limited.^[159]

Nuclear Waste Management Disputes

Disputes over nuclear waste management in radiochemistry primarily revolve around site selection for long-term geological disposal, the viability of fuel reprocessing versus direct burial, and tensions between empirical safety data and political opposition. In the United States, over 80,000 metric tons of spent nuclear fuel accumulate at reactor sites due to the absence of a federal repository, prompting interim dry cask storage that critics argue extends risks unnecessarily despite demonstrated containment efficacy.^[160] Proponents of advanced storage cite decades of incident-free operations, with no radiological releases from commercial spent fuel storage since the 1960s, underscoring that disputes often prioritize perceived hazards over verifiable containment performance.^[161] However, environmental advocacy groups and state governments frequently challenge approvals, amplifying concerns about groundwater migration or seismic vulnerabilities that modeling studies have quantified as low-probability events under engineered barriers.^[162] The Yucca Mountain project exemplifies these conflicts, selected under the 1982 Nuclear Waste Policy Act for a deep geological repository capable of holding 70,000 metric tons of waste, including 63,000 tons of commercial spent fuel.^[163] Nevada's opposition, rooted in claims of inadequate capacity and site-specific hydrology risks, culminated in the Obama administration's 2010 termination of funding before full licensing review, a decision upheld amid ongoing litigation despite prior Department of Energy assessments deeming the tuff rock formation suitable for isolation over 10,000 years.^[164] As of March 2025, the U.S. Supreme Court heard arguments on the Nuclear Regulatory Commission's approval of a private interim facility in Texas, highlighting interstate disputes where host states like Texas and New Mexico resist consolidated storage due to transportation hazards and precedent-setting fears, even as federal contracts mandate acceptance of waste.^[165] These cases reveal a pattern where scientific viability—supported by IAEA-endorsed multi-barrier designs—clashes with localized veto powers, delaying resolution for high-level wastes containing long-lived actinides like plutonium-239 (half-life 24,110 years).^[166] Parallel debates concern reprocessing spent fuel to extract uranium and plutonium for reuse, potentially reducing high-level waste volume by 90% and transuranic content, versus direct disposal in the once-through cycle.^[167] Advocates argue reprocessing, as practiced in France since 1976 via the PUREX process, minimizes radiotoxic inventory and leverages radiochemical separations to recycle 96% of fuel materials, with empirical data from La Hague showing effective management of vitrified wastes.^[168] Opponents, including a 2003 MIT analysis, contend it escalates costs—estimated at $1-2 billion annually for U.S.-scale operations—while heightening proliferation risks through separated plutonium, which could yield weapons-grade material absent stringent safeguards.^[169]^[170] U.S. policy, codified in the 1977 ban later partially lifted, favors disposal partly due to these nonproliferation priorities, though recent congressional reports note reprocessing could obviate permanent plutonium disposal needs if integrated with fast reactors, a path stalled by economic modeling showing once-through cycles remain cheaper through 2070.^[171]^[172] These disputes extend internationally, where Finland's Onkalo repository—approved in 2001 and under construction since 2004—progresses toward 2025 operations for 6,500 tons of spent fuel in crystalline bedrock, contrasting U.S. gridlock and attributing success to site-specific consent without federal overrides.^[162] In contrast, U.S. interim storage proliferation, with 54,000 metric tons in dry casks as of recent audits, fuels arguments for policy reform, as empirical transport data logs over 3,000 shipments without radiological incidents since 1964.^[160]^[161] Critics from academia and NGOs often frame these as existential threats, yet peer-reviewed assessments affirm geological disposal's feasibility, with disputes traceable to procedural inequities rather than insurmountable technical barriers.^[173] Resolution hinges on balancing radiochemical innovations, like advanced partitioning for minor actinides, against entrenched regulatory and public resistance.^[174]

Recent Advances

Innovations in Radiopharmaceuticals

Innovations in radiopharmaceuticals have centered on theranostic agents that pair diagnostic radionuclides for imaging with therapeutic counterparts for targeted radiation delivery, enabling personalized cancer treatment.^[106] This approach leverages molecular targeting to concentrate radiation at tumor sites while minimizing exposure to healthy tissues, with beta-emitting isotopes like lutetium-177 (Lu-177) proving effective in clinical settings.^[106] By 2025, the global radiopharmaceutical market had expanded to approximately $10.3 billion, projected to reach $21.9 billion by 2029, driven by these targeted therapies and advancements in production scalability.^[175] A pivotal development is the use of PSMA-targeted radiopharmaceuticals for prostate cancer, exemplified by lutetium Lu 177 vipivotide tetraxetan (Pluvicto), approved by the FDA in 2022 for PSMA-positive metastatic castration-resistant prostate cancer after androgen receptor pathway inhibition and taxane-based chemotherapy.^[106] Recent phase 3 trials, such as PSMAfore (2024), demonstrated that PSMA-targeted radioligand therapy extended radiographic progression-free survival to a median of 12 months versus 8.7 months with a change in ARPI, supporting expanded use before chemotherapy in metastatic hormone-sensitive settings.^[176] Similarly, trials like SPLASH and ECLIPSE in 2024 confirmed efficacy in earlier lines of therapy for metastatic castration-resistant prostate cancer, with overall survival benefits observed in PSMA-avid tumors.^[176] Alpha-emitting radiopharmaceuticals represent another frontier, offering higher linear energy transfer for potent cell-killing with shorter tissue penetration, reducing off-target damage compared to beta emitters.^[177] Radium-223 dichloride (Xofigo), an alpha emitter targeting bone metastases in castration-resistant prostate cancer, received FDA approval in 2013, but innovations in actinium-225 (Ac-225) conjugates have advanced to phase 1/2 trials by 2024, showing promising tumor regression in PSMA-expressing cancers with dosimetry indicating favorable safety profiles.^[178] The FDA granted breakthrough therapy designation to several Ac-225-based agents in 2023-2024, accelerating development for refractory solid tumors.^[178] Automated synthesis and chelation technologies have addressed supply chain bottlenecks for short half-life isotopes, enabling on-demand production of agents like Lu-177 PSMA-617, which improved dosing precision and reduced manual handling risks in clinical workflows.^[179] For neuroendocrine tumors, expansions of lutetium Lu 177 dotatate (Lutathera), FDA-approved in 2018, included new indications in 2024-2025 trials, with response rates exceeding 30% in somatostatin receptor-positive cases.^[180] These innovations underscore a shift toward precision oncology, though challenges persist in radionuclide availability and long-term toxicity data from ongoing longitudinal studies.^[181]

Emerging Analytical and Synthetic Methods

Microfluidic platforms have revolutionized radiochemical synthesis by enabling rapid, low-volume reactions that minimize radiation exposure and precursor use while accelerating production of short-lived isotopes for positron emission tomography (PET) imaging. These systems, often employing droplet-based or continuous-flow architectures, facilitate automated multi-step processes such as nucleophilic fluorination and chelation. For instance, in 2023, microfluidic cassettes were used to synthesize [68Ga]Ga-FAPI-46 and [68Ga]Ga-PSMA-11 with radiochemical yields exceeding 90% in under 15 minutes, demonstrating scalability for clinical theranostics.^[182] Similarly, the iMiDEV™ system, implemented in automated synthesizers by 2021 and refined thereafter, supports cassette-based production of [18F]-labeled tracers, reducing synthesis times to 5-10 minutes compared to conventional 30-60 minute batch methods.^[183] Automation via cassette-based and robotic modules further advances synthetic efficiency, allowing sequential production of multiple tracers on single platforms. A 2025 development enabled automated synthesis of both [18F]FDG and [68Ga]Ga-DOTA-TATE in sequence, achieving radiochemical purities over 95% and molar activities suitable for human dosing, which supports decentralized manufacturing near imaging sites.^[184] Copper-mediated radiofluorination, optimized through high-throughput experimentation (HTE) workflows integrating solid-phase extraction and parallel radio-thin-layer chromatography, has improved yields for aryl boronate precursors to 50-70% in automated settings since 2022.^[185] Click chemistry ligation strategies, updated in 2023, provide bioorthogonal tools for site-specific radiolabeling of biomolecules, with strains-promoted azide-alkyne cycloadditions yielding >80% incorporation of [18F] or [89Zr] in under 10 minutes under mild conditions.^[186] Emerging analytical methods emphasize high-sensitivity purity assessment and real-time monitoring to ensure radiopharmaceutical quality amid complex syntheses. High-throughput radio-TLC and HPLC integration in HTE platforms, as reported in 2025, allows parallel evaluation of dozens of reactions, identifying optimal conditions for fluorination with detection limits below 0.1% impurities.^[185] For therapeutic radionuclides like [177Lu]PSMA, multifactorial analysis combining reversed-phase HPLC and thin-layer chromatography in 2025 quantified radiochemical purity at >99.5% across high-activity batches, correlating decay-corrected yields with elution profiles to predict stability.^[187] Electrospray ionization mass spectrometry (ESI-MS) coupled with radio-HPLC, advanced in 2023 quality control protocols, detects metallic impurities and cold carriers in [18F] tracers at parts-per-billion levels, surpassing traditional gamma spectroscopy by providing molecular speciation.^[188] Laser-driven isotope production represents a novel synthetic-analytical hybrid, with ultra-intense, high-repetition-rate lasers generating [11C] via multi-shot proton irradiation of methane targets, yielding 10^9 atoms per shot in 2024 experiments—potentially enabling on-demand positron emitters without cyclotrons.^[189] These methods collectively address scalability challenges in radiochemistry, driven by empirical demands for higher throughput and purity in clinical applications.^[48]

Integration with Advanced Imaging

Radiochemistry enables the production of targeted radiotracers essential for advanced molecular imaging modalities, particularly positron emission tomography (PET) and single-photon emission computed tomography (SPECT), by incorporating radionuclides into biologically active molecules. These tracers exploit the decay emissions of isotopes such as fluorine-18 (half-life 109.8 minutes) for PET, which annihilates to produce coincident 511 keV photons detectable with high sensitivity, allowing quantification of tracer uptake at picomolar concentrations.^[102] In SPECT, gamma-emitting isotopes like technetium-99m (half-life 6.01 hours) are chelated to ligands via established radiochemical kits, providing functional insights with collimator-based detection, though with lower resolution than PET due to single-photon geometry.^[190] Recent innovations in radiochemical synthesis have enhanced integration with these techniques, including automated microfluidic platforms that achieve radiochemical yields exceeding 90% for 18F-labeled fluorodeoxyglucose (FDG) in under 10 minutes, minimizing precursor impurities and enabling on-demand production at clinical sites.^[102] Bioorthogonal click chemistry, such as strain-promoted azide-alkyne cycloaddition, facilitates site-specific radiolabeling of antibodies and nanoparticles post-injection, improving tumor targeting in PET while reducing nonspecific accumulation; for instance, 89Zr-labeled affibody molecules have demonstrated sub-millimeter resolution in preclinical models.^[191] For SPECT, advancements in chelator-free labeling of metal oxides with 99mTc have streamlined production, supporting hybrid SPECT/CT systems that fuse emission data with computed tomography for precise lesion localization, as validated in cardiac perfusion studies achieving 95% diagnostic accuracy.^[192] Hybrid imaging further amplifies radiochemical contributions, with PET/MRI combining positron detection and magnetic resonance for simultaneous functional-anatomical mapping, where radiotracers like 68Ga-DOTATATE (half-life 68 minutes) enable neuroendocrine tumor detection with reduced radiation exposure compared to PET/CT.^[193] Emerging theranostic applications integrate imaging with therapy, using radiochemistry to pair diagnostic isotopes (e.g., 18F for PET) with therapeutic analogs (e.g., 177Lu), as in prostate-specific membrane antigen-targeted agents approved by the FDA in 2022 for imaging-guided treatment.^[194] These developments underscore radiochemistry's role in overcoming limitations like short isotope half-lives through rapid, high-fidelity labeling, though challenges persist in scaling production for non-commercial tracers.^[195]

Education and Future Outlook

Training and Workforce Challenges

The radiochemistry workforce faces acute shortages exacerbated by an aging demographic and insufficient influx of new professionals. As of 2022, the field relies on a small, multidisciplinary cadre of experts vital for nuclear energy, medicine, and environmental monitoring, yet retirements are surging without adequate replacements, threatening advancements in cancer therapy and radiation research.^[196]^[2] Educational programs in radiochemistry have declined sharply since the 1980s, with a steady reduction in university chemistry departments offering graduate studies in nuclear or radiochemistry, driven by diminished federal funding post-Cold War and shifting academic priorities toward non-nuclear fields.^[197] Undergraduate concentrations remain scarce, with only a handful of U.S. institutions providing specialized training, while graduate programs, though existent, are fragile and under-resourced, often lacking faculty with requisite expertise to balance teaching demands.^[197]^[198] This scarcity hampers preparation for hands-on skills in isotope handling, hot-cell operations, and radiation safety protocols, which demand facilities and expertise not readily available in standard chemistry curricula.^[2] Emerging demands in radiotheranostics and nuclear medicine amplify these gaps, revealing marked shortages of trained radiochemists and radiopharmacists amid regulatory hurdles and limited access to production facilities.^[199] Initiatives like the University of Iowa's graduate certificate program address this by offering flexible, responsive training tailored to industry needs, yet broader stabilization requires increased funding for program expansion and interdisciplinary integration.^[198] Without such interventions, workforce deficits risk stalling innovations in energy security and medical isotopes.^[200]

Prospects for Expansion and Research Needs

Radiochemistry is experiencing renewed expansion potential, primarily driven by advancements in nuclear medicine and radiopharmaceutical development. The global nuclear medicine market, encompassing radiochemical applications, is projected to grow from USD 11.77 billion in 2025 to USD 42.03 billion by 2032, fueled by demand for targeted therapies such as radioligand therapy (RLT) and theranostics.^[201] This growth reflects increasing clinical adoption of radioisotopes for precision oncology, including alpha-emitting radionuclides like actinium-225 and lead-212, which enable more selective tumor destruction compared to traditional beta-emitters.^[202] Fundamental research opportunities also abound, as radiochemistry facilitates probing short-lived species and extreme reaction conditions inaccessible via conventional methods, potentially yielding insights into elemental reactivity and catalysis.^[48] Emerging applications extend beyond medicine into environmental monitoring, space exploration, and nanotechnology, where radiochemical tracers enhance sensitivity in detecting trace contaminants or isotopic signatures.^[203] Supply chain enhancements, including domestic isotope production initiatives in the United States and Europe, are poised to mitigate historical shortages, supporting broader field scalability.^[197] However, realizing this expansion requires addressing persistent bottlenecks in radionuclide availability and production efficiency. Key research needs include developing scalable methods for emerging radionuclides, such as improved cyclotron-based or generator systems to meet surging demand for theranostic pairs like lutetium-177 and gallium-68.^[181] Challenges in targetry, radiochemical separations, and target material recycling—particularly for enriched isotopes—persist, necessitating innovations in automated synthesis modules to reduce manual handling risks and enhance purity.^[204] ^[205] Regulatory harmonization and supply chain resilience are critical, as current limitations in specialized infrastructure hinder global distribution of short half-life agents.^[199] ^[206] Education and training gaps represent another priority, with calls for expanded curricula integrating radiochemistry into multidisciplinary programs to build a workforce proficient in handling logistics, safety protocols, and interdisciplinary applications like oncology-radiology integration.^[197] ^[48] Increased funding for these areas, as evidenced by recent U.S. Department of Energy initiatives, could accelerate progress, though empirical validation through pilot-scale demonstrations remains essential to overcome skepticism rooted in past supply disruptions.^[197] Prioritizing causal factors like production yield optimization over unsubstantiated regulatory expansions will ensure sustainable field growth.

References

[1]
Radiochemistry | Chemistry - College of Liberal Arts and Sciences
Radiochemistry is defined as the study of radioactive elements using chemical techniques. Some elements on the periodic table contain naturally occurring ...
[2]
Radiochemistry and nuclear chemistry workforce in the United States
Sep 21, 2022 · For example, radiochemistry may be defined as the application of the phenomena of radioactive decay and techniques common to nuclear physics so ...
[3]
Radiochemistry Renaissance - Science & Technology Review
Rather than turning lead into gold, Rutherford's discovery led to the founding of radiochemistry—the study of radioactive isotopes—and nuclear chemistry, which ...Missing: definition | Show results with:definition
[4]
History of Radiochemistry | Open Medscience
Jul 3, 2024 · Radiochemistry began with Becquerel's discovery, expanded by the Curies, and developed during the World Wars, with the Manhattan Project, and ...
[5]
History of Nuclear and Radiochemistry - SpringerLink
Two important developments in the early history of radioactivity were (1) the recognition of the three different types of radiation , α, β, and γ rays ...
[6]
Radiochemistry - SCK CEN
In the medical sector, for example, radiochemistry is used to produce medical radioisotopes and radiopharmaceuticals that are indispensable in the battle ...Development Of Radiochemical... · An Answer To Societal... · 3 Research Areas
[7]
Radioisotopes in Medicine - World Nuclear Association
Jan 10, 2025 · Radioisotopes are used for diagnosis, treatment, and sterilization in medicine. They are used in imaging and to study organ function.
[8]
12.4: Applications of Radioactivity - Chemistry LibreTexts
Jul 20, 2023 · Radioactivity has several practical applications, including tracers, medical applications, dating once-living objects, and the preservation ...
[9]
[PDF] Significant Discoveries and the History of Radiation Protection | EPA
By the 1930s, physicists were beginning to understand fission and radioactive decay, which led to the research and development of the first nuclear reactors ...
[10]
Henri Becquerel – Facts - NobelPrize.org
When Henri Becquerel investigated the newly discovered X-rays in 1896, it led to studies of how uranium salts are affected by light.
[11]
Becquerel discovers radioactivity | timeline.web.cern.ch
On 26 February 1896, he placed uranium salts on top of a photographic plate wrapped in black paper. The salts caused a blackening of the plate despite the paper ...
[12]
March 1, 1896: Henri Becquerel Discovers Radioactivity
Feb 25, 2008 · On an overcast day in March 1896, French physicist Henri Becquerel opened a drawer and discovered spontaneous radioactivity.
[13]
The discovery of radioactivity - ScienceDirect.com
The radioactivity of uranium was discovered in 1896 by Henri Becquerel who, starting from a wrong idea, progressively realized what he was observing.
[14]
Marie and Pierre Curie and the discovery of polonium and radium
Dec 1, 1996 · After thousands of crystallizations, Marie finally – from several tons of the original material – isolated one decigram of almost pure radium ...
[15]
The Curies Discover Radium - American Physical Society
It took Marie over three years to isolate one-tenth of a gram of pure radium chloride, and she never succeeded in isolating polonium because of its very short ...
[16]
Marie Curie the scientist | Bio, facts & quotes
In 1902 Marie eventually isolated radium (as radium chloride), determining its atomic weight as 225.93. The journey to discovery had been long and arduous.
[17]
MARIE CURIE - NobelPrize.org
Pierre Curie gave himself a lesion when he purposely exposed his arm to radium. Worse, however, was working for years in a poorly ventilated shed, isolating ...
[18]
Marie Curie - Research Breakthroughs (1897-1904)
These processes isolated from the pitchblende materials with high concentrations of radium and polonium, which the Curies studied in detail in what she called ...
[19]
Ernest Rutherford
In 1899 Ernest Rutherford studied the absorption of radioactivity by thin sheets of metal foil and found two components: alpha (a) radiation, which is absorbed ...
[20]
Ernest Rutherford – Facts - NobelPrize.org
In 1899 Ernest Rutherford demonstrated that there were at least two distinct types of radiation: alpha radiation and beta radiation. He discovered that ...
[21]
The Story of the Discovery of the Nucleus | Exploring Radioactivity
Together with Soddy, Rutherford firmly established the existence and regularity of radioactive decay. Also at McGill, Rutherford collaborated with the chemists ...
[22]
Ernest Rutherford - radioactivity.eu.com
He identified in particular the nature of alpha and beta rays and formulated the law of radioactive decay. © ACJC. In October 1895, landed in England a 24 years ...
[23]
Manhattan Project: People > Scientists > GLENN T. SEABORG
Seaborg's primary assignment was to develop a process for the chemical separation of plutonium within a matter of months. Seaborg's team developed a number ...
[24]
Seaborg and Plutonium Chemistry - Atomic Archive
The two decided to pursue all four methods of plutonium separation but put first priority on the lanthanum fluoride process Seaborg had already developed.
[25]
[PDF] Glenn T. Seaborg - Nobel Lecture
The isolation of the plutonium was to be done by chemical means, and in the spring of 1942, I and a number of my colleagues moved to the Metallurgical.<|separator|>
[26]
Chemical Separation - Plutonium Production - OSTI.GOV
The Metallurgical Laboratory, under the leadership of the chemist Glenn Seaborg, was responsible for plutonium separation research. Seaborg's team developed ...
[27]
Manhattan Project - Manhattan Project National Historical Park (U.S. ...
During this time, nuclear science advanced at an exponential rate. New discoveries were made in rapid succession.Beyond The Manhattan Project · Learn About Hanford, WA · Los Alamos, NM
[28]
Introduction: The Atomic Century
This chapter provides a brief survey of the development of radiation research and the changing roles of the biomedical researcher.
[29]
Beyond the bomb: Atomic research changed medicine, biology
Feb 27, 2014 · These advances were made possible by the availability of radioisotopes, which are radioactive isotopes, or variants, of stable atoms. In the ...Missing: radiochemistry | Show results with:radiochemistry
[30]
Glenn Seaborg: plutonium and beyond | Feature - Chemistry World
Feb 24, 2012 · While working on plutonium he had detected further transuranium elements and wanted to complete – and publish – his investigations. But ...
[31]
Outline History of Nuclear Energy
Jul 17, 2025 · The science of atomic radiation, atomic change and nuclear fission was developed from 1895 to 1945. From 1945 attention was given to ...Missing: radiochemistry | Show results with:radiochemistry
[32]
Assuring a Future U.S.-Based Nuclear and Radiochemistry Expertise
This report answers these questions by building on past efforts to assess needs in nuclear and radiochemistry and nuclear science and engineering more broadly, ...Missing: post- | Show results with:post-<|separator|>
[33]
Comparison of the Chernobyl and Fukushima nuclear accidents
The environmental effects of Chernobyl and Fukushima are compared. · Releases of radionuclides from Chernobyl exceeded Fukushima by an order of magnitude.
[34]
Chernobyl radionuclides in the environment: tracers for the tight ...
Chernobyl radionuclides in the environment: tracers for the tight coupling of atmospheric, terrestrial, and aquatic geochemical processes | Environmental ...
[35]
Radioactive contaminated forests in Fukushima and Chernobyl
This paper compares the scale and consequences of radioactive contamination of forest ecosystems following the Chernobyl and Fukushima accidents.
[36]
Fukushima and Chernobyl: Similarities and Differences of ... - NIH
In the case of Fukushima, radiocesium leaching from CsMPs can be expected to be comparable or even slower than that from Chernobyl-origin fuel particles, and ...
[37]
Radiochemistry and nuclear chemistry workforce in the United States
Sep 21, 2022 · This chapter provides a brief update of the current state of, and critical U.S. needs for, nuclear chemistry and radiochemistry expertise as the ...<|separator|>
[38]
Fifty Years of Radiopharmaceuticals | Journal of Nuclear Medicine ...
Jun 1, 2020 · Key developments include FDA regulation, 99mTc and 18F-FDG, 99mTc-sestamibi, and the first FDA-approved monoclonal antibody for tumor imaging.
[39]
Radiochemistry, PET Imaging, and the Internet of Chemical Things
Aug 16, 2016 · Reflecting this, the early homemade remote synthesis systems of the 1980s (Figure 1A) were gradually replaced in the 1990s–2000s by more ...
[40]
The chemical tool-kit for molecular imaging with radionuclides in the ...
Jan 30, 2021 · Radiolabelling antibodies has been a focus of radiochemists since the 1980s, as highlighted above, but the demand to extend imaging with ...
[41]
Trends in nuclear medicine and the radiopharmaceutical sciences in ...
Here, we discuss the key challenges and opportunities that face the field as it seeks to build its workforce for the 21st century.
[42]
Trends in Nuclear Medicine and the Radiopharmaceutical Sciences ...
The last two decades, however, have played witness to a remarkable surge in the clinical application of diagnostic and therapeutic radiopharmaceuticals, ...<|separator|>
[43]
Copper-mediated radiochemistry: historical impact, current trends ...
Jun 10, 2025 · One of the most significant radiochemical advancements of the last decade has been the introduction of a new class of copper-mediated ...
[44]
Chemical experiments with superheavy elements - PubMed
These 'superheavy' elements (also called transactinides with atomic number > or = 104 (Rf)) have been artificially synthesized in fusion reactions at ...
[45]
Open questions on chemistry in the synthesis and characterization ...
Jun 10, 2021 · Superheavy elements are ideal for furthering our understanding of relativistic effects and how they affect physicochemical properties of ...
[46]
Synthesis of superheavy elements using radioactive beams and ...
Synthesis of superheavy elements using radioactive beams and targets. Author ... Expected decay properties and half-lives of superheavy elements are discussed.Missing: radiochemistry | Show results with:radiochemistry
[47]
Radiopharmaceutical Industry Trends Shaping 2025 - Forbes
Feb 20, 2025 · 1. Continued Innovation Powering Exceptional Growth · 2. Advances In Radiochemistry And Isotope Production · 3. Integration Of AI In Nuclear ...
[48]
Radiochemistry: A Hot Field with Opportunities for Cool Chemistry
Nov 14, 2023 · This recent renaissance of radiochemistry is paired with new opportunities to study fundamental chemical behavior and reactivity of elements.
[49]
Radioactive Decay | US EPA
Jun 24, 2025 · Radioactive decay is the emission of energy in the form of ionizing radiation. ionizing radiation Radiation with so much energy it can knock electrons out of ...
[50]
24.2: Nuclear Decay Processes - Chemistry LibreTexts
Mar 20, 2025 · Radioactive decay involves the emission of a particle and/or energy as one atom changes into another. · Alpha ( α ) decay involves the release of ...Nuclear Decay Processes · Alpha Emission · Beta Emission · Positron Emission
[51]
Nuclear decay
Alpha decay is a form of radioactive decay in which an atomic nucleus characterized by mass number A and atomic number Z ejects an alpha particle (a 4He nucleus) ...
[52]
DOE Explains...Beta Decay - Department of Energy
The second type of beta decay is beta-plus decay. In this form, the nucleus emits a neutrino and a positron (the antimatter form of an electron). This process ...
[53]
Other types of radioactive decay - ARPANSA
Spontaneous fission · Neutron emission · Positron or beta plus (β+) emission · Electron capture · Internal conversion · Other types of decay.Spontaneous fission · Neutron emission · Positron or beta plus (β+...
[54]
7.1: Gamma Decay - Physics LibreTexts
Mar 3, 2022 · Gamma decay is the third type of radioactive decay. Unlike the two other types of decay, it does not involve a change in the element.Quantum mechanical theory · The vector potential · Dipole transition for gamma...<|separator|>
[55]
[PDF] Manual for reactor produced radioisotopes
Types of nuclear reactions. Some of the major nuclear reactions that are used for radioisotope production are given below: 4. Page 11. 1.3.3.1. (n,J) reaction.
[56]
[PDF] Nuclear Data for the Production of Therapeutic Radionuclides
The assembly of a credible database involved new measurements on the production of some specific radionuclides via charged particle induced reactions, and the ...
[57]
[PDF] Cyclotron Produced Radionuclides: Physical Characteristics and ...
Nuclear reactions. The nuclear reactions for the production of 68Ge are the alpha reaction on natural zinc and the proton reaction on either natural gallium ...
[58]
Production of novel diagnostic radionuclides in small medical ...
Feb 20, 2018 · Cyclotron produced radionuclides Among these classical radionuclides are: 18F, 13N, 11C and 15O. These four PET radionuclides are also commonly ...Cyclotron Produced... · Types Of Cyclotrons · Technetium-99m
[59]
[PDF] Cyclotron Produced Radionuclides: Principles and Practice
The use of nuclear reactors for the production of radioisotopes relies on the fact that during the fission process in a reactor, there are large numbers of.
[60]
[PDF] Photonuclear Production of Radioisotopes - Publications
A photonuclear reaction is a nuclear reaction induced by photon. Photonuclear reactions occur when atomic nuclei are excited via the capture of incident photons ...
[61]
[PDF] Charged particle cross-section database for medical radioisotope ...
In addition to medical radioisotope production, reactions with low energy charged particles are of primary importance for two major applications. Techniques of ...
[62]
Radioactive Equilibrium | Definition & Theory | nuclear-power.com
In the physics of nuclear decays, a radioactive equilibrium exists when a radioactive nuclide is decaying at the same rate at which it is being produced.Missing: principles | Show results with:principles
[63]
Decay Chains - Oregon State Ecampus
Secular Equilibrium · Example: 226Ra (half-life =1620 yr) decays to 226Rn (half-life 4.8 days). · The observation period is so small relative to 1620 years that 1 ...
[64]
Transient Equilibrium - Radioactive Equilibrium | nuclear-power.com
The transient radioactive equilibrium exists when the half-life of the parent nucleus is longer than the half-life of the daughter nucleus.
[65]
[PDF] Radionuclide Generators & Equilibrium Overview
Definition: Equilibrium is a condition established in a parent/daughter mixture when both parent and daughter are radioactive and when the daughter's half-life ...
[66]
[PDF] Calculation of Equilibrium Constants for Isotopic Exchange Reactions
Tables and approximation methods are given which permit a rapid calculation of equilibrium constants if the frequency shifts on isotopic substitution are known.
[67]
The isotope effects in the isotope exchange equilibria of lithium in ...
The elementary separation factors for lithium isotopes in the isotope-exchange equilibria between the amalgam and the organic solution have been measured at ...
[68]
[PDF] Hot-atom chemistry - University of Michigan Library
Hot-atom chemistry (HAC) is the study of the chemical reactions that occur between high-energy atoms and ions and (usually) thermal-energy atoms, molecules,.
[69]
Hot Atom Chemistry and Radiopharmaceuticals - AIP Publishing
It is quite simply a detailed study of the molecular dynamics of newly formed radioactive atoms. A new radionuclide is formed through either a nuclear reaction, ...
[70]
(PDF) Hot Atom Chemistry and Radiopharmaceuticals - ResearchGate
Nov 8, 2016 · This review uses some well-known examples to understand how hot atom chemistry explains the primary products from a nuclear reaction and then ...
[71]
A study of ion exchange equilibria using radioactive isotopes
The ion exchange equilibrium was determined for Fe, Mn, Ni, Co, Sr, Rb, Ba, and Cs ions using tracer technique. Based on these data column operations were.
[72]
Radionuclide Production: Methods and Applications
Jun 28, 2024 · Radionuclide production involves reactor-based, cyclotron, and generator methods, providing crucial applications in medicine and industry.
[73]
Radionuclide production - Currie - 2011 - Wiley Online Library
Oct 2, 2013 · The common methods of radionuclide production for nuclear medicine include: fission, neutron activation, cyclotron and generator.
[74]
Production Methods | NIDC - National Isotope Development Center
Radioisotopes can be produced in reactors by exposing suitable target materials to the intense reactor neutron flux for an appropriate time.
[75]
Radionuclide Production, Radiopharmaceuticals, and Internal ...
May 16, 2021 · Cyclotrons and other charged-particle accelerators produce radionuclides by bombarding stable nuclei with high-energy charged particles.
[76]
[PDF] Radionuclide Production
There are two main methods of performing this bombardment. 1. Inserting target in a nuclear reactor - fine for longer-lived isotopes.
[77]
Full article: State of the Art in Cyclotrons for Radionuclide Production ...
Jan 11, 2023 · Cyclotrons accelerating hydrogen ions up to 30 MeV have contributed to the production of a variety of SPECT radionuclides, like 123I, 67Ga, 201 ...
[78]
Radionuclide Generator - an overview | ScienceDirect Topics
A radionuclide generator consists of an apparatus that allows separation of the product of radionuclide decay from the source radionuclide.
[79]
Radionuclide generators: the prospect of availing PET radiotracers ...
This overview outlines a critical assessment of RNGs to avail PET tracers, the contemporary status of RNGs, and key challenges and apertures to the near future.
[80]
Research Progress on Major Medical Radionuclide Generators - MDPI
This article reviews the latest research progress on three main medical radioactive isotope generators of 99 Mo/ 99 mTc, 68 Ge/ 68 Ga, and 90 Sr/ 90 Y.
[81]
In Vivo Radionuclide Generators for Diagnostics and Therapy - PMC
In vivo radionuclide generators make complex combinations of physical and chemical properties available for medical diagnostics and therapy.<|control11|><|separator|>
[82]
[PDF] MARLAP Manual Volume II: Chapter 14, Separation Techniques
This chapter provides: (1) a review of the important chemical principles underlying radiochemical separations, (2) a survey of the important separation methods ...
[83]
Radiochemical Separation Techniques in Classroom Settings
Mar 16, 2023 · The three radiochemical separation techniques discussed are coprecipitation, liquid–liquid extraction, and ion-exchange chromatography.
[84]
Standard Methods: 7500-Ra B: Radium by Precipitation
The determination of radium by precipitation includes all alpha-emitting radium isotopes; it is a screening technique particularly applicable to drinking water.
[85]
Perspectives on the Use of Liquid Extraction for Radioisotope ... - NIH
Jan 18, 2019 · Industrial solvent extraction (also known as liquid-liquid extraction, LLE) was pioneered for the separation and recovery of radioactive ...
[86]
SOLVENT EXTRACTION IN RADIOCHEMICAL SEPARA TIONS1,2
One of the major objectives of solvent extrac tion theory is to develop expressions based on considerations of the various chemical equilibria involved in ...
[87]
Opportunities and challenges of high-pressure ion exchange ...
In the Manhattan project, ion exchange chromatography (IEC) was used with great success in the separation and purification of fission rare earth elements.
[88]
[PDF] Application of Ion Exchange Processes for the Treatment of ...
Ion exchange is a common and effective treatment method for liquid radioactive waste, and is a well developed technique.
[89]
[PDF] Application of Distillation Techniques to Radiochemical Separations
The use of vacuum distillation of inorganic compounds and metals for radiochemical separations is reviewed. A brief description of the experimental ...
[90]
Emerging role of electrochemistry in radiochemical separation of ...
This article is a comprehensive summary of the electrochemical processes developed for the separation of radiometals that could be used for diagnostic or ...
[91]
Introduction to Radiation Detectors - Mirion Technologies
These are: Gas-Filled Detectors, Scintillators, and Solid State detectors. Each has various strengths and weaknesses that recommend them to their own specific ...
[92]
Detection and Measurement of Radioactivity - NDE-Ed.org
Radioactivity is detected using devices like electroscopes, cloud chambers, and ionization chambers, which use ionization or molecular excitation processes.
[93]
32: Radiochemical Methods - Chemistry LibreTexts
Sep 4, 2022 · There are three common types of detectors: gas-filled detectors, scintillation counters, and semiconductor detectors. 32.3: Neutron Activation ...
[94]
Measuring Radiation | Nuclear Regulatory Commission
Radiation is measured using four units: radioactivity (Ci, Bq), exposure (R, C/kg), absorbed dose (rad, Gy), and dose equivalent (rem, Sv). These are ...Missing: techniques | Show results with:techniques
[95]
Measurement of Radioactivity - NCBI
Jun 1, 2021 · Radioactivity is measured using spectrometers, radiometers, and dosimeters. Spectrometers provide detailed radiation info, radiometers measure ...
[96]
[PDF] Radiochemical Analysis: Techniques and their Applications
Techniques such as solvent extraction, ion exchange chromatography, and precipitation are commonly employed to separate radioactive isotopes from interfering ...
[97]
Radiochemical Analysis in Nuclear Energy: Key Techniques and QA ...
Jul 17, 2025 · Standard techniques include thermal ionization mass spectrometry (TIMS) and inductively coupled plasma mass spectrometry (ICP-MS) with collision ...
[98]
[PDF] Radiochemical analysis - NIST Technical Series Publications
... Radiochemical Analysis. Section retains the radiation techniques and radioisotope tech- niques groups. In addition, the Radiochemical Analysis Section.
[99]
SAM Radiochemical Methods | US EPA
Dec 31, 2024 · SAM provides a list of analytical methods to be used in analyzing environmental samples and outdoor building materials for radiochemical contaminants.
[100]
https://www.iaea.org/nuclear-science/isotopes/radiopharmaceutical-production
[101]
A Step-by-Step Guide for the Novel Radiometal Production for ... - NIH
The majority of radionuclides produced using cyclotrons utilize the “Target Material (p,xn)Desired Radionuclide” nuclear reaction. Cyclotrons are classified ...<|separator|>
[102]
Radiochemistry for positron emission tomography - Nature
Jun 5, 2023 · In this work, we provide an overview of commonly used chemical transformations for the syntheses of PET tracers in all aspects of radiochemistry.
[103]
Radiotheranostics: a roadmap for future development - PMC - NIH
The concept of radiotheranostics has been around for more than 70 years, prime examples include using different forms of radioactive iodine to diagnose (eg, ...
[104]
Radiopharmaceutical therapy in cancer: clinical advances and ...
Jul 29, 2020 · Radiopharmaceutical therapy (RPT) is emerging as a safe and effective targeted approach to treating many types of cancer.
[105]
What Is Theranostics? - Journal of Nuclear Medicine
May 1, 2023 · Thus, the combination of PSMA PET and external-beam radiotherapy is also an example of theranostics according to our definition. In addition to ...
[106]
Radiopharmaceuticals and their applications in medicine - Nature
Jan 3, 2025 · In the second half of the 20th century, the era of inventing nuclear medicine devices and their applications began. The advancements, from gamma ...
[107]
Radiochemical Analyses | Wisconsin State Laboratory of Hygiene
Radiochemistry – Radiochemical Analyses. Air Analyses. Gross Alpha/Beta; Radon 222. Soil, Silt and Sludge Analyses. Gamma Scan; Gross Alpha/Beta; Radium 226.
[108]
SAM 2022 Radiochemical Methods Query | US EPA
Feb 18, 2025 · SAM provides guidance for selecting radiochemical methods that have a high likelihood of assuring analytical consistency when laboratories are ...
[109]
Dynamic Flow Approaches for Automated Radiochemical Analysis ...
Versatile flow approaches have been utilized in different steps for radiochemical analysis, including sample pretreatment, chemical separation/purification, ...<|separator|>
[110]
Short-lived U/Th Series Radionuclides in the Ocean: Tracers for ...
Mar 3, 2017 · The short-lived particle reactive radionuclides of the U/Th series also have enormous potential for tracking particle source and transport in ...
[111]
Combined Use of Short-Lived Radionuclides ( 234 Th and 210 Po ...
Jan 17, 2024 · Naturally occurring radionuclides, such as 234Th and 210Po, have been used as powerful particle tracers in the marine environment to study ...
[112]
Chapter 2 Radionuclides as Tracers and Timers of Processes in the ...
This chapter discusses the basic principles underlying the various applications of environmental radionuclides in tracer studies of terrestrial systems.Missing: geochemistry | Show results with:geochemistry
[113]
Short-lived natural radionuclides as tracers in hydrogeological studies
Apr 10, 2024 · Long-lived radionuclides, such as 3 H, 14 C, 36 Cl, 39 Ar, 81 Kr, and 85 Kr, are well-established as tools for dating of groundwaters older than ten years.
[114]
Editorial: Natural and artificial radionuclides as tracers of ocean ...
Mar 30, 2023 · Anthropogenic radionuclides (e.g., 137Cs) distributed at global or regional scales are useful tracers for validating and refining ocean-earth ...
[115]
Radioisotopes in Industry - World Nuclear Association
Apr 22, 2025 · Radioisotopes are used by manufacturers as tracers to monitor fluid flow and filtration, detect leaks, and gauge engine wear and corrosion of process equipment.
[116]
[PDF] How Radioisotopes Support Industrial Processes | IAEA
Gauges using radioisotopes and radiation are used for a number of industrial applications such measuring water and sediment mixture density, level ...
[117]
[PDF] List of Some Major Uses of Radioisotopes in the United States
Used to sterilize surgical instruments and to improve the safety and reliability of industrial fuel oil burners. Used in cancer treatment, food irradiation ...<|separator|>
[118]
Radiation Safety and Protection - StatPearls - NCBI Bookshelf
Following the ALARA principle, health care workers should confirm that the benefits of the exposure outweigh the risks and strive to decrease radiation exposure ...
[119]
Guidelines for ALARA – As Low As Reasonably Achievable - CDC
Feb 26, 2024 · ALARA means avoiding exposure to radiation that does not have a direct benefit to you, even if the dose is small.
[120]
Dose limits - ICRPaedia
Dose limits ensure no excessive radiation exposure. Occupational limit is 20 mSv/year (averaged over 5 years, no single year exceeding 50 mSv). 1 mSv/year for ...
[121]
[PDF] Radiation Protection and Safety of Radiation Sources
The IAEA establishes safety standards for radiation protection, including the "Radiation Protection and Safety of Radiation Sources: International Basic Safety ...
[122]
Subpart C—Occupational Dose Limits
(ii) A shallow-dose equivalent of 50 rem (0.5 Sv) to the skin of the whole body or to the skin of any extremity. (b) Doses received in excess of the annual ...
[123]
What Does ALARA Mean and Why Is It So Important? - landauer
Jul 22, 2024 · ALARA is the guiding principle of radiation safety. The main purpose of ALARA is to protect employee health and establish a safe working ...
[124]
Radiation Safety in Medicine and Laboratories - UNC EHS
In general, there is no radiation hazard from the sources in patients who have received diagnostic or tracer doses of radioactive materials.
[125]
Radioactive Material Safety Policies - Radiation Safety Office
BASIC LABORATORY PRACTICES · Wear personal dosimeters (e.g., film badge, ring badge, or pocket dosimeter). · Wear protective clothing, such as lab coats, full- ...<|separator|>
[126]
Radiation Safety Laboratory Guidance
Radiation Safety requires that you label your radioisotope use rooms (laboratories) with Caution Radioactive Material signs, authorized personnel notice, and ...
[127]
ICRP Guidance for Occupational Exposure
Normal limits are 20 mSv/year (100 mSv in 5 years), with 50 mSv max in a single year. No dose restrictions if benefit outweighs risk. Pregnant/nursing workers ...
[128]
Health Hazard of the Tokaimura Nuclear Accident - J-Stage
Three workers were heavily exposed to radiations in the Tokaimura nuclear accident, and one of them died due to the acute effects of radiations.
[129]
an experience at the Tokaimura criticality accident - PubMed
Nov 10, 2021 · Two of these workers developed severe bone marrow failure and received haematopoietic stem cell transplantation: one with peripheral stem cell ...Missing: health effects
[130]
Lung, liver and bone cancer mortality in Mayak workers - PMC
The Mayak worker study provides the only direct evidence that internal plutonium exposure increases cancer risks in humans. On the basis of individual improved ...
[131]
Radiation Effects on Mortality from Solid Cancers Other than Lung ...
The results of these analyses of the Mayak worker cohort clearly demonstrate increased cancer risks following prolonged low dose rate radiation exposure.
[132]
Cancer mortality after low dose exposure to ionising radiation in ...
Aug 16, 2023 · The estimated rate of mortality due to solid cancer increased with cumulative dose by 52% (90% confidence interval 27% to 77%) per Gy, lagged by 10 years.
[133]
Health Effects of Occupational and Environmental Exposures to ...
Jun 18, 2024 · Workers exposed to radiation from nuclear power plants had a lower risk for all-cancer (RR 0.85, 95% CI: 0.75 to 0.97; p = 0.013) compared to ...
[134]
Epidemiological research on radiation-induced cancer in atomic ...
The risk of leukemia among the survivors increased remarkably in the early period after the bombings, especially among children. Increased risks of solid ...
[135]
A decade after the Fukushima accident - the UNSCEAR
Mar 9, 2025 · UNSCEAR said that future health effects, eg cancer directly related to radiation exposure are unlikely to be discernible, in its 2020 Report launched today.
[136]
Radiological Fate & Transport | US EPA
Jun 9, 2025 · Radiological Fate & Transport. Radiological contaminants can travel throughout the built and natural environment. A radiological release ...
[137]
The effect of climate change on sources of radionuclides to ... - Nature
Mar 16, 2024 · Climate change interacts with the sources and cycling of contaminants, such as radionuclides, in the environment. In this review, we discuss ...<|separator|>
[138]
Fate and transport of radionuclides in soil-water environment. Review.
The ease in which radionuclides move through the environment and are taken up by plants and animals is governed by their chemical forms and by site-specific ...
[139]
Effect of Atmospheric Stability on the Dispersion of Radioactive ...
How does atmospheric stability affect the dispersion of radioactive material? The spread of plume will be larger in a more unstable atmosphere.<|separator|>
[140]
Aerosol dynamics and dispersion of radioactive particles - ACP
Apr 1, 2021 · Atmospheric dispersion models are used to simulate how various kinds of pollutants disperse in the atmosphere. Dispersion models for ...
[141]
Dispersion and ground deposition of radioactive material according ...
This study presents a methodology to estimate the atmospheric transport, dispersion and ground deposition patterns of radioactive particles.
[142]
Behaviour of long-lived Chernobyl radionuclides in a soil-water system
Radionuclide species have different pathways and rates of migration in soils and bottom sediments. Migration of each chemical form was described by a ...
[143]
Migration of 137 Cs in the soil of sloping semi-natural ecosystems in ...
Horizontal migration depends mainly on water runoff, the quantity of radionuclides in the upper surface layers, and its water solubility (Arapis and Karandinos ...
[144]
Risks from radionuclide migration to groundwater in the Chernobyl ...
The risk from contaminated groundwater is lower than other pathways, and off-site risks are below the level requiring counter-measures.
[145]
Transport and fate of radionuclides in aquatic environments - PubMed
An aquatic ecosystem model for the environmental transport of radionuclides is presented and discussed.
[146]
MITgcm-RN v1.0: Modeling the Transport and Fate of Radionuclides ...
Jul 9, 2025 · This study demonstrates the effectiveness of our modeling tool, which can be broadly applied to assess the transport and fate of other types of ...
[147]
[PDF] Radiological Bioconcentration Factors for Aquatic, Terrestrial, and ...
Bioconcentration factors can also be used to estimate bioaccumulation factors, dose assessment, and as a means to predict ecological risk to organisms in the ...
[148]
Bioaccumulation of radionuclides in fertilized Canadian Shield lake ...
Our objective was to determine the uptake of the radionuclides by biota and the effect of lake trophic status on their bioaccumulation. The trophic status of ...
[149]
Radiophobia: long-term psychological consequences of Chernobyl
Abstract. The primary health effect of Chernobyl has been widespread psychological distress in liquidators (workers brought in for cleanup), evacuees, residents ...Missing: scientific studies
[150]
Radiophobia: Useful concept, or ostracising term? - ScienceDirect
Radiophobia can still be regarded as a useful concept to try and explain the extreme risk perception divergence that exists between nuclear experts and the ...
[151]
Radiophobia. Why the fallout of unscientific myths from Chernobyl ...
Sep 12, 2021 · It is no secret that the Chernobyl accident and the displacement led to mental health issues in forms of depression, suicides, alcoholism and ...
[152]
Fact Sheet: Nuclear Medicine and Radiation Safety - SNMMI
Each year, more than 20 million Americans benefit from nuclear medicine procedures, which use small amounts of radioactive materials, called ...
[153]
Facts About Nuclear Medicine | Radiation and Your Health - CDC
Feb 20, 2024 · Nuclear medicine can show how the organs or tissues are functioning. For most diagnostic procedures, a tracer, which contains the radioactive ...
[154]
Low-dose ionizing radiation as a hormetin - PubMed Central - NIH
Jan 9, 2021 · In these studies, the mean lifespan was often increased by 10–30% while the maximal lifespan has been usually unchanged (Calabrese and Baldwin ...Missing: empirical | Show results with:empirical
[155]
Radiation Hormesis: Historical Perspective and Implications for Low ...
In contrast, with the hormetic model, low doses of radiation reduce the cancer incidence while it is elevated after high doses. Based on a review of ...
[156]
Low Dose Ionising Radiation-Induced Hormesis: Therapeutic ... - MDPI
Radiation hormesis is the phenomena whereby low doses of ionising radiation provoke a stimulatory or beneficial effect in otherwise unstressed cells, but ...Missing: empirical | Show results with:empirical
[157]
PART 20—STANDARDS FOR PROTECTION AGAINST RADIATION
(a) The regulations in this part establish standards for protection against ionizing radiation resulting from activities conducted under licenses issued by the ...
[158]
Radiochemicals: Down But Not Out - C&EN
Apr 5, 2010 · Working with radiochemicals is challenging, Mayer says, and many young researchers avoid them, preferring to rely on fluorescence, stable ...
[159]
The NRC's new Mission Impossible: Making Atoms Great Again
May 29, 2025 · For decades, the nuclear industry has blamed overregulation for the cost overruns and delays that have plagued new projects and caused it to ...Missing: research | Show results with:research
[160]
[PDF] Solving the U.S. Nuclear Waste Dilemma - CURIE
More than 54,000 MTiHM is civilian SNF now being stored in reactor pools or in dry storage air-cooled containers at sites contiguous to the 131 civilian nuclear.
[161]
[PDF] Disposal and Storage of Spent Nuclear Fuel — Finding the Right ...
The safety record has been very good and cor- roborates the low risks estimated analytically. In fact, during the decades that spent fuel has been shipped ...
[162]
[PDF] Issues in radioactive waste disposal
Plans for disposing of radioactive wastes have raised a number of unique and mostly philosophical problems, mainly due to the very long time-scales which have ...
[163]
Backgrounder on Licensing Yucca Mountain
The proposed repository would hold 70,000 metric tons of waste. This amount would include 63,000 metric tons of commercial spent nuclear fuel. More than 77,000 ...
[164]
Why US nuclear waste policy got stalled. And what to do about it.
Jul 31, 2024 · The Yucca Mountain project was stalled indefinitely by the Obama administration before any substantive licensing hearing took place. It was not ...
[165]
Supreme Court steps into debate over where to store nuclear waste
Mar 5, 2025 · The Supreme Court on Wednesday jumped into the decades-long dispute over what to do with thousands of metric tons of nuclear waste.
[166]
[PDF] IAEA Safety Standards Storage of Radioactive Waste
The regulatory body should periodically verify the acceptability of key aspects of the storage operation, such as the keeping of records, inventories and.<|control11|><|separator|>
[167]
Processing of Used Nuclear Fuel
Aug 23, 2024 · The economics of reprocessing and associated waste disposal have improved; There is now a lot of experience with civil reprocessing. Soon ...
[168]
Recycling Nuclear Waste: A Win-Win or a Dangerous Gamble?
Apr 2, 2025 · Recycling would not only shrink the volume of radioactive material that would eventually need to be buried underground, advocates say, but it ...
[169]
Why the US doesn't recycle spent nuclear fuel - Project Optimist
Feb 21, 2024 · A now-famous 2003 MIT study concluded that reprocessing isn't worth the cost or the risk of proliferation. The paper recommended at least for ...
[170]
[PDF] the economics of reprocessing versus direct disposal of spent ...
We conclude that the once-through LWR fuel cycle is likely to remain sig- nificantly cheaper than recycling in either LWRs or FRs for at least the next 50 yr, ...
[171]
Considerations for Reprocessing of Spent Nuclear Fuel
Jan 23, 2025 · In principle, indefinite reprocessing of SNF could eliminate the need for permanent disposal of uranium and plutonium, which would be made into new fuel.
[172]
The Economics of Reprocessing vs. Direct Disposal of Spent ...
For decades, there has been an intense debate over the best approach to managing spent fuel from nuclear power reactors, whether it is better to dispose of it ...
[173]
Procedural fairness and safety in the acceptance of nuclear waste ...
In this study, we further investigate the relationship between perceived fairness, trust, in terms of confidence and acceptance of the site selection procedure.
[174]
The Debate on Nuclear Waste Recycling: Balancing Safety ...
Jun 9, 2025 · One of the biggest concerns is that reprocessing fuel rods and pellets produces plutonium, a key component of nuclear weapons.
[175]
Innovations Drive Growth in $21.9 Billion Radiopharmaceutical ...
May 2, 2025 · The global radiopharmaceuticals market is expected to grow from $10.3 billion in 2024 and is projected to reach $21.9 billion by the end of 2029 ...
[176]
2024 theranostic radiopharmaceuticals recap - Nucleus RadioPharma
Dec 2, 2024 · With trials such as PSMAfore, SPLASH, and ECLIPSE, the targeted RLT was studied in mCRPC before a patient received chemotherapy. All three of ...
[177]
Emerging Trends in Radiopharmaceuticals - Blog - TD2 Oncology
Oct 30, 2024 · New developments in alpha-emitting radioisotopes like actinium-225 and astatine-211 are driving innovation in radiopharmaceutical therapy. These ...
[178]
Radiopharmaceutical Therapy Innovations & Global Clinical Trial ...
Jun 19, 2024 · Current FDA-approved alpha emitters include Radium-223 (Xofigo™). Recent developments also saw the FDA granting breakthrough device designation ...
[179]
Radiopharmaceuticals Market to Double by 2029 – Here's Why
May 10, 2025 · Technological Innovations Driving the Market · Targeted Alpha Therapy (TAT) · Theranostics · Automated Radiopharmaceutical Production · Next- ...
[180]
Radiopharma Powerhouses Push Frontiers With New Indications ...
May 12, 2025 · Another area of active innovation in radiopharma involves the targeting moiety, which is used to deliver the therapeutic element to the cancer ...
[181]
Recent Advances and Impending Challenges for the ...
Indeed, the increased clinical use of radiopharmaceuticals for both diagnosis and therapy, a surge in regulatory approvals, and an upwelling of preclinical ...
[182]
Microfluidic-based production of [68Ga]Ga-FAPI-46 and [68Ga]Ga ...
Dec 13, 2023 · The synthesis box allows us to perform radiochemistry using the microfluidic cassette and reagents. The control module assists in performing all ...
[183]
Implementation of iMiDEV™, a new fully automated microfluidic ...
Apr 26, 2021 · iMiDEV™ microfluidic system is a new automated tool for a small-scale production of radiopharmaceuticals. This new radiochemistry module ...<|separator|>
[184]
Sequential Synthesis of [18F]FDG and [68Ga]Ga-DOTA-TATE on the ...
May 7, 2025 · The development of our sequential automated synthesis system represents a significant advancement in PET imaging agent production. The ability ...
[185]
Development of High-Throughput Experimentation Approaches for ...
Apr 17, 2025 · This report describes an experimental and analytical workflow for evaluating high throughput radiochemistry via SPE purification and parallel ...
[186]
Click Chemistry and Radiochemistry: An Update - ACS Publications
Sep 22, 2023 · In this update, we seek to provide a comprehensive guide to recent developments at the intersection of click chemistry and radiopharmaceutical chemistry.
[187]
Multifactorial analysis of radiochemical purity in high-activity 177Lu ...
Jul 22, 2025 · Additionally, radiochemical purity was assessed through two complementary analytical methods: HPLC and Thin Layer Chromatography (TLC). TLC ...Missing: advances | Show results with:advances
[188]
New Analytical Methods Used for Quality Control of ...
Oct 23, 2023 · In a recent study, researchers introduced several analytical techniques, such as ESI-MS, RP-HPLC, and ICP-MS, to separate and detect various ...Missing: emerging radiochemistry
[189]
Production of carbon-11 for PET preclinical imaging using a high ...
May 20, 2024 · We report for the first time the use of a high-repetition rate, ultra-intense laser system for the production of carbon-11 in multi-shot operation.Missing: emerging | Show results with:emerging
[190]
Radiopharmaceuticals for PET and SPECT Imaging - PubMed Central
In recent years, developments in SPECT imaging systems based on new solid-state cadmium telluride and zinc telluride (CZT) crystals and collimator design led ...
[191]
Recent Advances in Bioorthogonal Click Chemistry for Enhanced ...
Feb 22, 2023 · We provide a summary of recent advances in radiotracers prepared using bioorthogonal click reactions, including small molecules, peptides, proteins, antibodies ...
[192]
New Radionuclides and Technological Advances in SPECT and ...
Dec 8, 2021 · Developments throughout the history of nuclear medicine have involved improvements in both instrumentation and radionuclides, which have been intertwined.
[193]
Editorial: Insights in PET and SPECT: 2023 - Frontiers
Radiomics aims to enhance the potential of medical imaging through mathematical extraction and analysis of the spatial distribution of signal intensities and ...
[194]
Recent advances in emerging radiopharmaceuticals and the ...
Theranostic radiopharmaceuticals have the potential to drive substantial progress in cancer diagnose and treatment. •. Radionuclide production, chemistry ...
[195]
Exploring the radiochemistry of PARP inhibitors: a new era in ...
Jul 3, 2025 · The radiochemistry of PARP inhibitors involves incorporating radioisotopes (most of all Fluorine-18) into the molecular structure of these molecules.
[196]
Alarm sounded over declining US radiation professional workforce
As retirements surge, shortages threaten to slow advances in cancer therapy, diagnostics, and improved understanding of the physiological impacts of radiation.
[197]
Radiochemistry education and demand.
Jun 12, 2025 · This paper examines the current state of radiochemistry education and workforce needs in the United States.
[198]
https://link.springer.com/article/10.1007/s10967-025-10400-y
[199]
Implementation of Radiotheranostics: Challenges, Barriers, and ...
Aug 31, 2025 · Key challenges include limited access to radionuclide production facilities, regulatory hurdles, insufficient workforce training, inadequate ...
[200]
[PDF] Radiochemistry education and demand
Jun 12, 2025 · This study reviews available undergraduate and graduate programs in radiochemistry, including degrees, specializations, and research.
[201]
Nuclear Medicine Market Size & Global Growth Report [2032]
Oct 6, 2025 · The global nuclear medicine market size was valued at USD 10.19 billion in 2024. The market is projected to grow from USD 11.77 billion in 2025 to USD 42.03 ...Missing: radiochemistry | Show results with:radiochemistry
[202]
Radiopharmaceutical Industry Outlook: Growth Trends and Future ...
Jun 25, 2024 · The field of radiotherapeutics has seen rapid development due to advances in radioisotope-based therapies, multimodality bioimaging technology, ...<|separator|>
[203]
14.4 Emerging trends and future prospects in radiochemistry
Advanced analytical techniques, such as accelerator mass spectrometry and synchrotron-based X-ray spectroscopy, have enhanced the sensitivity and ...Radiopharmaceuticals And... · Environmental And Forensic... · Radiochemistry In Advanced...
[204]
Highlight selection of radiochemistry and radiopharmacy ...
Oct 3, 2025 · This study determined critical parameters and established optimal labeling and accurate measuring techniques for radiochemical yield and purity ...Missing: 1990-2025 | Show results with:1990-2025
[205]
Highlight selection of radiochemistry and radiopharmacy ...
Oct 3, 2025 · Selected highlight articles · A simplified radiosynthetic approach to 18F-labelling BODIPY dyes using indium salts as ideal Lewis acid mediators.Missing: peer- | Show results with:peer-
[206]
Navigate the Global Nuclear Medicine Supply Chain in 2025
Break down the full supply chain—from isotope production to patient delivery—and uncover the pressure points impacting RLT growth.<|separator|>